[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 230
1. Reddy PP, Rao RR, Shashidhar J, Sastry BS, Rao JM, Babu KS: Phytochemical investigation of labdane diterpenes from the rhizomes of Hedychium spicatum and their cytotoxic activity. Bioorg Med Chem Lett; 2009 Nov 1;19(21):6078-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In addition, all the isolates were tested for their cytotoxicity against the THP-1 (human acute monocytic leukemia), HL-60 (human promyelocytic leukemia), A-375 (human malignant melanoma) and A-549 (human lung carcinoma) cancerous cell lines.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19782567.001).
  • [ISSN] 1464-3405
  • [Journal-full-title] Bioorganic & medicinal chemistry letters
  • [ISO-abbreviation] Bioorg. Med. Chem. Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / 14,15,16-trinor-7,11-labdadien-13-oic acid; 0 / 7-hydroxy-15,16-epoxy-17-al-7,11,13(16),14-labdatetraene-6-one; 0 / Antineoplastic Agents, Phytogenic; 0 / Diterpenes; 0 / Plant Extracts
  •  go-up   go-down


2. Li L, Zhang AH, Liu LB, Bi L, Wang L, Zhao YJ, Zou P: [Effect of down-regulating mll-af9 gene expression on proliferation of acute monocytic leukemia cell line THP-1]. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr;16(2):254-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Effect of down-regulating mll-af9 gene expression on proliferation of acute monocytic leukemia cell line THP-1].
  • This study was aimed to investigate the effect of small interfering RNA (siRNA) on the expression of mll-af9 oncogene and the proliferation of human acute monocytic leukemia cell line THP-1.
  • Then the obtained siRNA was transfected into cultured human acute monocytic leukemia cell line THP-1 by lipofectamine.
  • It is concluded that the mll-af9-targeted siRNA can effectively inhibit the proliferation of human acute monocytic leukemia cell line THP-1.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18426643.001).
  • [ISSN] 1009-2137
  • [Journal-full-title] Zhongguo shi yan xue ye xue za zhi
  • [ISO-abbreviation] Zhongguo Shi Yan Xue Ye Xue Za Zhi
  • [Language] CHI
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / MLL-AF9 fusion protein, human; 0 / Oncogene Proteins, Fusion; 0 / RNA, Messenger; 0 / RNA, Small Interfering; 149025-06-9 / Myeloid-Lymphoid Leukemia Protein
  •  go-up   go-down


3. Takashi S, Park J, Fang S, Koyama S, Parikh I, Adler KB: A peptide against the N-terminus of myristoylated alanine-rich C kinase substrate inhibits degranulation of human leukocytes in vitro. Am J Respir Cell Mol Biol; 2006 Jun;34(6):647-52
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In additional studies using human leukocyte cell lines, secretion of eosinophil peroxidase from the eosinophil-like cell line HL-60 clone 15, lysozyme from the monocytic leukemia cell line U937, and granzyme from the lymphocyte natural killer cell line NK-92 were attenuated by preincubation of the cells with MANS but not with the missense control peptide.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. 12-O-TETRADECANOYLPHORBOL-13-ACETATE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Exp Biol Med (Maywood). 2002 Sep;227(8):645-51 [12192108.001]
  • [Cites] Pharmacol Ther. 2005 Sep;107(3):358-76 [15951020.001]
  • [Cites] Physiol Rev. 2003 Apr;83(2):581-632 [12663867.001]
  • [Cites] J Immunol. 2003 May 15;170(10):5276-80 [12734377.001]
  • [Cites] J Allergy Clin Immunol. 2003 May;111(5):923-32; quiz 933 [12743551.001]
  • [Cites] J Biol Chem. 2003 Dec 5;278(49):48898-902 [14506265.001]
  • [Cites] Nat Med. 2004 Feb;10(2):193-6 [14716307.001]
  • [Cites] Blood. 2004 Aug 1;104(3):832-9 [15073033.001]
  • [Cites] Int J Cancer. 1976 May 15;17(5):565-77 [178611.001]
  • [Cites] J Immunol Methods. 1987 Nov 23;104(1-2):183-90 [3500234.001]
  • [Cites] Nature. 1988 Mar 24;332(6162):362-4 [3352735.001]
  • [Cites] Leuk Res. 1988;12(8):679-86 [3184985.001]
  • [Cites] J Exp Med. 1989 Jul 1;170(1):163-76 [2473157.001]
  • [Cites] Biochem J. 1990 Feb 15;266(1):195-200 [2138016.001]
  • [Cites] Blood. 2000 Feb 1;95(3):894-902 [10648401.001]
  • [Cites] J Allergy Clin Immunol. 2000 Apr;105(4):651-63 [10756213.001]
  • [Cites] Biochimie. 2000 Apr;82(4):339-52 [10865122.001]
  • [Cites] Am J Pathol. 2005 Sep;167(3):651-61 [16127146.001]
  • [Cites] J Hematother Stem Cell Res. 2001 Jun;10(3):369-83 [11454312.001]
  • [Cites] J Appl Physiol (1985). 2001 Aug;91(2):613-22 [11457772.001]
  • [Cites] J Biol Chem. 2001 Nov 2;276(44):40982-90 [11533058.001]
  • [Cites] J Leukoc Biol. 2002 Apr;71(4):701-10 [11927658.001]
  • [Cites] Biochim Biophys Acta. 1990 Apr 9;1052(1):133-42 [2322590.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Aug;87(15):5603-7 [2116001.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Dec;87(23):9472-6 [1979172.001]
  • [Cites] Nature. 1991 May 23;351(6324):320-2 [2034276.001]
  • [Cites] Nature. 1992 Apr 16;356(6370):618-22 [1560845.001]
  • [Cites] J Leukoc Biol. 1992 Aug;52(2):173-82 [1506773.001]
  • [Cites] Nature. 1993 Mar 25;362(6418):318-24 [8455717.001]
  • [Cites] Leukemia. 1994 Apr;8(4):652-8 [8152260.001]
  • [Cites] Biochim Biophys Acta. 1994 Sep 8;1223(2):267-73 [8086498.001]
  • [Cites] J Leukoc Biol. 1995 Jul;58(1):49-54 [7616105.001]
  • [Cites] Cell Immunol. 1995 Sep;164(2):234-9 [7656332.001]
  • [Cites] J Biol Chem. 1996 Aug 2;271(31):18797-802 [8702537.001]
  • [Cites] Blood. 1997 May 15;89(10):3503-21 [9160655.001]
  • [Cites] J Immunol. 1998 Feb 1;160(3):1385-92 [9570558.001]
  • [Cites] Blood. 1999 Jul 1;94(1):23-32 [10381494.001]
  • [Cites] J Immunol. 2003 Mar 1;170(5):2670-9 [12594296.001]
  • (PMID = 16543603.001).
  • [ISSN] 1044-1549
  • [Journal-full-title] American journal of respiratory cell and molecular biology
  • [ISO-abbreviation] Am. J. Respir. Cell Mol. Biol.
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / R37 HL36982
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / MARCKS-related peptide; 0 / Peptide Fragments; EC 1.11.1.- / Eosinophil Peroxidase; EC 1.11.1.7 / Peroxidase; EC 3.2.1.17 / Muramidase; EC 3.4.21.- / Granzymes; EC 3.4.21.- / Serine Endopeptidases; EC 3.4.21.78 / GZMA protein, human; NI40JAQ945 / Tetradecanoylphorbol Acetate
  • [Other-IDs] NLM/ PMC2644225
  •  go-up   go-down


Advertisement
4. Liang YH, Li P, Zhao JX, Liu X, Huang QF: [Acetyl-11-keto-beta-boswellic acid and arsenic trioxide regulate the productions and activities of matrix metalloproteinases in human skin fibroblasts and human leukemia cell line THP-1]. Zhong Xi Yi Jie He Xue Bao; 2010 Nov;8(11):1060-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Acetyl-11-keto-beta-boswellic acid and arsenic trioxide regulate the productions and activities of matrix metalloproteinases in human skin fibroblasts and human leukemia cell line THP-1].
  • We combined AKBA and ATO as a compound, and explored its regulatory role in productions and activities of matrix metalloproteinase (MMP)-1, MMP-2 and MMP-9 in human skin fibroblasts (HSFbs) and human acute monocytic leukemia cell line THP-1 in inflammatory state.

  • Hazardous Substances Data Bank. ARSENIC TRIOXIDE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21078271.001).
  • [ISSN] 1672-1977
  • [Journal-full-title] Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine
  • [ISO-abbreviation] Zhong Xi Yi Jie He Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Arsenicals; 0 / Oxides; 0 / Triterpenes; 0 / acetyl-11-ketoboswellic acid; EC 3.4.24.- / Matrix Metalloproteinases; S7V92P67HO / arsenic trioxide
  •  go-up   go-down


5. Yoshimura N, Kinoshita M, Teramoto T: Isolation and characterization of apolipoprotein B48-containing lipoproteins with a monoclonal antibody against apolipoprotein B48. J Atheroscler Thromb; 2009;16(6):740-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Furthermore, the uptake of apoB48-containing lipoproteins by THP-1 cells (a human acute monocytic leukemia cell line) , HepG2 cells (a human hepatoma cell line) , and human umbilical vein endothelial cells (HUVEC) was investigated.

  • MedlinePlus Health Information. consumer health - Diabetes Type 2.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19661723.001).
  • [ISSN] 1880-3873
  • [Journal-full-title] Journal of atherosclerosis and thrombosis
  • [ISO-abbreviation] J. Atheroscler. Thromb.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Apolipoprotein B-48; 0 / Chylomicrons; 0 / Lipoproteins
  •  go-up   go-down


6. Wang C, Chen Z, Li Z, Cen J: The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells. Leuk Res; 2010 Aug;34(8):1083-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
  • The frequency of extramedullary infiltration (EMI) in acute myeloblastic leukemia (AML) is reported up to 40% and most prevalent in myelo-monoblastic and monoblastic subtypes of AML (M4 and M5 according to FAB classification).
  • To explore mechanism underlying EMI, we analyzed SHI-1 cells, a highly invasive human acute monocytic leukemia cell line, and found their strong expression of matrix metalloproteinase 2 (MMP-2), membrane type 1 MMP (MT1-MMP) and tissue inhibitor of metalloproteinase 2 (TIMP-2).
  • SHI-1 cells showed higher invasive ability to traverse reconstituted basement membranes (Matrigel) and stronger activation of proMMP-2 than other leukemia cell line such as NB4, K562, U937 and THP-1 cells.
  • [MeSH-major] Leukemia, Monocytic, Acute / metabolism. Leukemia, Monocytic, Acute / pathology. Matrix Metalloproteinase 14 / metabolism. Matrix Metalloproteinase 2 / metabolism. Tissue Inhibitor of Metalloproteinase-2 / metabolism

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Elsevier Ltd. All rights reserved.
  • (PMID = 20138666.001).
  • [ISSN] 1873-5835
  • [Journal-full-title] Leukemia research
  • [ISO-abbreviation] Leuk. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Drug Combinations; 0 / Laminin; 0 / Matrix Metalloproteinase Inhibitors; 0 / Proteoglycans; 0 / RNA, Messenger; 0 / RNA, Small Interfering; 119978-18-6 / matrigel; 127497-59-0 / Tissue Inhibitor of Metalloproteinase-2; 9007-34-5 / Collagen; EC 3.4.24.24 / Matrix Metalloproteinase 2; EC 3.4.24.80 / MMP14 protein, human; EC 3.4.24.80 / Matrix Metalloproteinase 14
  •  go-up   go-down


7. Araya-Maturana R, Cardona W, Cassels BK, Delgado-Castro T, Ferreira J, Miranda D, Pavani M, Pessoa-Mahana H, Soto-Delgado J, Weiss-López B: Effects of 9,10-dihydroxy-4,4-dimethyl-5,8-dihydro-1(4H)-anthracenone derivatives on tumor cell respiration. Bioorg Med Chem; 2006 Jul 1;14(13):4664-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The title compound, which proved to be the most active one, also exhibited low micromolar dose-dependent growth inhibition of the human tumor U937 cell line (human monocytic leukemia).
  • Also, the inhibition of oxygen uptake by 6-(4-methylpent-3-enyl)-1,4-naphthoquinone was determined and compared with its reported cytotoxicity toward P-388 (murine lymphocytic leukemia), A-549 (human lung carcinoma), HT-29 (human colon carcinoma), and MEL-28 (human melanoma) cells.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16504517.001).
  • [ISSN] 0968-0896
  • [Journal-full-title] Bioorganic & medicinal chemistry
  • [ISO-abbreviation] Bioorg. Med. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / 4,4-dimethyl-5,8-dihydroxynaphthalene-1-one; 0 / Anthracenes; 0 / Antineoplastic Agents; 0 / Naphthalenes
  •  go-up   go-down


8. Altieri A, Castro F, Bermejo JL, Hemminki K: Number of siblings and the risk of lymphoma, leukemia, and myeloma by histopathology. Cancer Epidemiol Biomarkers Prev; 2006 Jul;15(7):1281-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Number of siblings and the risk of lymphoma, leukemia, and myeloma by histopathology.
  • Epidemiologic evidence indicates that several markers of exposure to childhood infections are inversely associated with the risk of childhood leukemia and lymphomas.
  • Having four or more siblings compared with none was associated with an excess risk of childhood acute lymphoblastic leukemia [ALL; rate ratio (RR), 2.11; P(trend) = 0.001], acute monocytic leukemia (RR, 2.51; P(trend) = 0.002), and multiple myeloma (RR, 1.34; P(trend) = 0.006).
  • Having three or more older siblings compared with none decreased the risk of acute monocytic leukemia (RR, 0.35; P(trend) = 0.001) and childhood ALL (RR, 0.69; P(trend) = 0.01).
  • Acute myeloid leukemia, chronic lymphocytic leukemia, and other lymphoproliferative malignancies were not associated with number of siblings.
  • In conclusion, we found an excess risk of childhood ALL and acute monocytic leukemia in large families.
  • However, for ALL, acute monocytic leukemia, and Hodgkin's lymphoma, younger siblings were strongly protected compared with older siblings.
  • The remarkable protective effect of number of older siblings on acute monocytic leukemia is a novel finding of potential interest.
  • [MeSH-major] Birth Order. Hodgkin Disease / etiology. Leukemia / etiology. Multiple Myeloma / etiology. Siblings

  • MedlinePlus Health Information. consumer health - Childhood Leukemia.
  • MedlinePlus Health Information. consumer health - Hodgkin Disease.
  • MedlinePlus Health Information. consumer health - Leukemia.
  • MedlinePlus Health Information. consumer health - Multiple Myeloma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16835324.001).
  • [ISSN] 1055-9965
  • [Journal-full-title] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
  • [ISO-abbreviation] Cancer Epidemiol. Biomarkers Prev.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


9. Wu HJ, Chen Y: [Biological characteristics of hyperleukocytic acute leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Jun;14(3):450-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Biological characteristics of hyperleukocytic acute leukemia].
  • The study was to investigate the biological characteristics of hyperleucocyte acute leukemia (HAL) and its clinical significance.
  • In AML, monocytic leukemia is easier to become into HAL than other leukemias.
  • In ALL, T-lineage antigens of HAL group are more easily expressed than those of NHAL group; the leukemia cells of HAL group are naiver than those of NHAL group, meanwhile the prognosis of HAL is poor.

  • MedlinePlus Health Information. consumer health - Acute Myeloid Leukemia.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16800918.001).
  • [ISSN] 1009-2137
  • [Journal-full-title] Zhongguo shi yan xue ye xue za zhi
  • [ISO-abbreviation] Zhongguo Shi Yan Xue Ye Xue Za Zhi
  • [Language] CHI
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD14; 0 / Antigens, CD79; 0 / Antigens, CD8; 0 / Sialic Acid Binding Ig-like Lectin 2
  •  go-up   go-down


10. Li Z, Kustikova OS, Kamino K, Neumann T, Rhein M, Grassman E, Fehse B, Baum C: Insertional mutagenesis by replication-deficient retroviral vectors encoding the large T oncogene. Ann N Y Acad Sci; 2007 Jun;1106:95-113
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Primary hematopoietic stem/progenitor cells transduced with retroviral vectors encoding TAg-induced histiocytic sarcoma (HS) or myeloid leukemia (ML) in transplanted mice (average survival of 21 weeks).
  • Retrovirally introducing TAg into pretransformed 32D cells generated a monocytic leukemia, with faster kinetics ( approximately 8 weeks).
  • 32D-derived monocytic leukemias showed hits in Pim2 and Max proto-oncogenes, or the chaperone Hspa4, plus additional signaling genes.

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17395733.001).
  • [ISSN] 0077-8923
  • [Journal-full-title] Annals of the New York Academy of Sciences
  • [ISO-abbreviation] Ann. N. Y. Acad. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Viral, Tumor
  •  go-up   go-down


11. Ning BT, Tang YM, Xu Y, Chen YF, Cao J: [Establishment of murine cell line transfected with human CD14 gene]. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr;14(2):388-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This study was aimed to construct the CD14 eukaryotic expression vector, establish the transgeneic CD14 positive cell line in order to facilitate the establishment of a mouse model of antibody targeting therapy for human acute monocytic leukemia (AML-M(5)).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16638222.001).
  • [ISSN] 1009-2137
  • [Journal-full-title] Zhongguo shi yan xue ye xue za zhi
  • [ISO-abbreviation] Zhongguo Shi Yan Xue Ye Xue Za Zhi
  • [Language] CHI
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD14; 0 / Antigens, Neoplasm
  •  go-up   go-down


12. Hu XR, He JS, Ye XJ, Zheng WY, Wu WJ, Lin MF: Candida tropicalis arthritis in a patient with acute leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct;16(5):1215-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Candida tropicalis arthritis in a patient with acute leukemia.
  • A case of Candida tropicalis arthritis of knee occurred in a patient with acute monocytic leukemia was reported during the recovery phase of post chemotherapy myelosuppression and agranulocytosis.

  • Genetic Alliance. consumer health - Arthritis.
  • MedlinePlus Health Information. consumer health - Infectious Arthritis.
  • MedlinePlus Health Information. consumer health - Leukemia.
  • MedlinePlus Health Information. consumer health - Yeast Infections.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18928631.001).
  • [ISSN] 1009-2137
  • [Journal-full-title] Zhongguo shi yan xue ye xue za zhi
  • [ISO-abbreviation] Zhongguo Shi Yan Xue Ye Xue Za Zhi
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antifungal Agents
  •  go-up   go-down


13. Sheng LX, Xie XB, Qiu GQ, Gu WY, Wang ZL, Wu HQ: [In vitro stimulation of specific antileukemia T-cell response by dendritic cells derived from CD14+ acute monocytic leukemia cells]. Ai Zheng; 2005 Nov;24(11):1338-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [In vitro stimulation of specific antileukemia T-cell response by dendritic cells derived from CD14+ acute monocytic leukemia cells].
  • BACKGROUND & OBJECTIVE: Dendritic cells (DCs) or DC-like cells had been successfully induced in vitro from leukemia cells, which may provide a promising immunotherapeutic protocol for leukemia.
  • This study was designed to investigate the efficiency of in vitro generation of dendritic cells from CD14+ acute myelomonocytic (M4) or monocytic (M5) leukemia cells and their ability of stimulating specific antileukemia T-cell response.
  • METHODS: Bone marrow mononuclear cells (BMMNCs) were isolated from 5 M4/M5 leukemia patients with high CD14 expression, and then divided into 3 groups: adherent leukemia cells, nonadherent blasts, and total unfractioned blasts.
  • When cultured with or without granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-4 (IL-4) and tumor necrosis factor alpha (TNF-alpha) for 7-10 days, monocytic leukemia cell-derived dendritic cells (Mo-LDCs) were identified through morphologic observation and immunophenotype analysis using FCM.
  • RESULTS: The amount of CD14+ cells, which could differentiate into CD83+ mature DCs under induction of the cytokine combination, was higher in adherent leukemia cells than in nonadherent blasts and total unfractioned blasts.
  • Mo-LDCs exhibited typical morphology and phenotype as mature DCs, induced potent proliferation of homogeneous T cells in Allo-MLR, stimulated the expansion of leukemia-specific CTLs, and continued to possess the cytogenetic abnormalities of the original leukemia, as well as the aberrant expression of myeloid antigens.
  • CONCLUSIONS: In M4/M5 subtype of AML, CD14+ cells could differentiate into immune-competent Mo-LDCs under the induction of the cytokine combination.
  • CD14 expression level may predict the DCs differentiation ability of monocytic leukemia.
  • Mo-LDCs, which possess the classical phenotype and function of DCs, as well as the abnormal leukemic antigens, may be useful for the immunotherapy of M4/M5 AML.
  • [MeSH-major] Antigens, CD14 / analysis. Dendritic Cells / immunology. Leukemia, Monocytic, Acute / pathology. T-Lymphocytes, Cytotoxic / immunology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16552959.001).
  • [Journal-full-title] Ai zheng = Aizheng = Chinese journal of cancer
  • [ISO-abbreviation] Ai Zheng
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, CD14; 0 / CD83 antigen; 0 / Immunoglobulins; 0 / Membrane Glycoproteins
  •  go-up   go-down


14. Amchenkova AM, Narovlianskiĭ AN, Cheknev SB, Bartova LM, Kulagina NN: [Capacity of fusicoccin for inducing the production of early interferon]. Zh Mikrobiol Epidemiol Immunobiol; 2005 Mar-Apr;(2):69-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In vitro experiments also revealed that the action of FC inhibited the metabolism of actively proliferating monocytic leukemia cells J-96 and human ovarian carcinoma cells CaOv, as well as mouse fibroblasts L-929.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15881944.001).
  • [ISSN] 0372-9311
  • [Journal-full-title] Zhurnal mikrobiologii, epidemiologii, i immunobiologii
  • [ISO-abbreviation] Zh. Mikrobiol. Epidemiol. Immunobiol.
  • [Language] rus
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Russia (Federation)
  • [Chemical-registry-number] 0 / Glycosides; 0 / Mycotoxins; 20108-30-9 / fusicoccin; 9008-11-1 / Interferons
  •  go-up   go-down


15. Johnson ES, Ndetan H, Lo KM: Cancer mortality in poultry slaughtering/processing plant workers belonging to a union pension fund. Environ Res; 2010 Aug;110(6):588-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Significantly increased risks were observed in the cohort as a whole or in subgroups, for several cancer sites, viz: cancers of the buccal cavity and pharynx; pancreas; trachea/bronchus/lung; brain; cervix; lymphoid leukemia; monocytic leukemia; and tumors of the hemopoietic and lymphatic systems.

  • MedlinePlus Health Information. consumer health - Occupational Health.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Inc. All rights reserved.
  • [ErratumIn] Environ Res. 2011 Jan;111(1):188-90
  • (PMID = 20541185.001).
  • [ISSN] 1096-0953
  • [Journal-full-title] Environmental research
  • [ISO-abbreviation] Environ. Res.
  • [Language] eng
  • [Grant] United States / NIOSH CDC HHS / OH / 1R01OH008071; United States / Intramural NIH HHS / /
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  •  go-up   go-down


16. Higashihara M, Watanabe M, Usuda S, Miyazaki K: Smooth muscle type isoform of 20 kDa myosin light chain is expressed in monocyte/macrophage cell lineage. J Smooth Muscle Res; 2008 Feb;44(1):29-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We previously reported the cloning of the full-length cDNAs of 20 kDa regulatory myosin light chain (MLC-2), named as MLC-2A, from Meg-01, a human megakaryoblastic leukemia cell line (J.
  • We now cloned another MLC-2 isoforms from human platelets and U937, a human monocytic leukemia cell line, named as MLC-2B and MLC-2C, respectively.
  • On the other hand, MLC-2C mRNA was expressed in untreated monocytic cell lines (U937 and A-THP-1) and HL-60 differentiated into monocyte/macrophage cell lineage by TPA treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18480596.001).
  • [ISSN] 0916-8737
  • [Journal-full-title] Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi
  • [ISO-abbreviation] J Smooth Muscle Res
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Myosin Light Chains; 0 / Protein Isoforms; 0 / RNA, Messenger; 0 / myosin light chain 2; EC 3.6.1.- / Cardiac Myosins
  •  go-up   go-down


17. Taki T, Akiyama M, Saito S, Ono R, Taniwaki M, Kato Y, Yuza Y, Eto Y, Hayashi Y: The MYO1F, unconventional myosin type 1F, gene is fused to MLL in infant acute monocytic leukemia with a complex translocation involving chromosomes 7, 11, 19 and 22. Oncogene; 2005 Aug 4;24(33):5191-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The MYO1F, unconventional myosin type 1F, gene is fused to MLL in infant acute monocytic leukemia with a complex translocation involving chromosomes 7, 11, 19 and 22.
  • We analysed a complex translocation involving chromosomes 7, 11, 19 and 22 in infant acute monocytic leukemia, and identified that the MLL gene on 11q23 was fused to the unconventional myosin type 1F, MYO1F, gene on 19p13.2-13.3.
  • [MeSH-major] DNA-Binding Proteins / genetics. Leukemia, Monocytic, Acute / genetics. Myosin Type I / genetics. Proto-Oncogenes / genetics. Transcription Factors / genetics. Translocation, Genetic
  • [MeSH-minor] Amino Acid Sequence. Base Sequence. Cell Line, Tumor. Chromosomes, Human, Pair 11. Chromosomes, Human, Pair 19. Chromosomes, Human, Pair 22. Chromosomes, Human, Pair 7. Female. Gene Rearrangement. Histone-Lysine N-Methyltransferase. Humans. Infant. Molecular Sequence Data. Myeloid-Lymphoid Leukemia Protein

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15897884.001).
  • [ISSN] 0950-9232
  • [Journal-full-title] Oncogene
  • [ISO-abbreviation] Oncogene
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA-Binding Proteins; 0 / MLL protein, human; 0 / Transcription Factors; 149025-06-9 / Myeloid-Lymphoid Leukemia Protein; EC 2.1.1.43 / Histone-Lysine N-Methyltransferase; EC 3.6.1.- / Myosin Type I
  •  go-up   go-down


18. Schmutz C, Cartwright A, Williams H, Haworth O, Williams JH, Filer A, Salmon M, Buckley CD, Middleton J: Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation. Arthritis Res Ther; 2010;12(4):R161
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tumour necrosis factor alpha (TNFα) increased CCR9 expression on human acute monocytic leukemia cell line THP-1 monocytic cells.

  • Genetic Alliance. consumer health - Arthritis.
  • Genetic Alliance. consumer health - Rheumatoid arthritis.
  • MedlinePlus Health Information. consumer health - Rheumatoid Arthritis.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arthritis Rheum. 2010 Jul;62(7):1921-32 [20506316.001]
  • [Cites] IDrugs. 2010 Jul;13(7):472-81 [20582872.001]
  • [Cites] Eur J Immunol. 2000 Jan;30(1):262-71 [10602049.001]
  • [Cites] J Immunol. 2000 Feb 1;164(3):1293-305 [10640743.001]
  • [Cites] Ann Rheum Dis. 2000 May;59(5):399-400 [10836959.001]
  • [Cites] J Exp Med. 2000 Sep 4;192(5):761-8 [10974041.001]
  • [Cites] J Immunol. 2000 Nov 1;165(9):5069-76 [11046037.001]
  • [Cites] Gastroenterology. 2001 Aug;121(2):246-54 [11487533.001]
  • [Cites] Arthritis Rheum. 2001 Dec;44(12):2750-60 [11762935.001]
  • [Cites] Arthritis Rheum. 2002 Oct;46(10):2578-86 [12384915.001]
  • [Cites] J Clin Invest. 2002 Oct;110(8):1113-21 [12393847.001]
  • [Cites] Microcirculation. 2003 Jun;10(3-4):313-23 [12851648.001]
  • [Cites] Ann Rheum Dis. 2003 Aug;62(8):715-21 [12860725.001]
  • [Cites] Ther Apher Dial. 2003 Feb;7(1):48-59 [12921115.001]
  • [Cites] J Exp Med. 2003 Sep 15;198(6):963-9 [12963696.001]
  • [Cites] Cancer Res. 2003 Oct 1;63(19):6469-77 [14559839.001]
  • [Cites] Int J Biochem Cell Biol. 2004 Mar;36(3):372-8 [14687914.001]
  • [Cites] Ann Rheum Dis. 1991 Oct;50(10):673-6 [1958087.001]
  • [Cites] Ann Rheum Dis. 1994 May;53(5):315-22 [8017985.001]
  • [Cites] J Rheumatol. 1994 May;21(5):830-5 [7520499.001]
  • [Cites] J Rheumatol. 1994 Sep;21(9):1608-14 [7799336.001]
  • [Cites] J Exp Med. 1995 May 1;181(5):1857-62 [7536797.001]
  • [Cites] Arthritis Rheum. 1996 Jan;39(1):115-24 [8546720.001]
  • [Cites] Immunity. 1997 Aug;7(2):291-301 [9285413.001]
  • [Cites] Drugs Aging. 1998 May;12(5):377-90 [9606615.001]
  • [Cites] Arthritis Rheum. 1998 Nov;41(11):2032-8 [9811059.001]
  • [Cites] J Immunol. 1999 May 15;162(10):5671-5 [10229797.001]
  • [Cites] Clin Cancer Res. 2004 Dec 15;10(24):8743-50 [15623660.001]
  • [Cites] J Immunol. 2005 Feb 1;174(3):1693-700 [15661933.001]
  • [Cites] Arthritis Res Ther. 2005;7(2):R217-29 [15743468.001]
  • [Cites] Arthritis Rheum. 2005 Mar;52(3):710-21 [15751074.001]
  • [Cites] Ann Rheum Dis. 2005 Jun;64(6):834-8 [15576415.001]
  • [Cites] Arthritis Rheum. 2005 Aug;52(8):2331-42 [16052590.001]
  • [Cites] J Immunol. 2005 Aug 15;175(4):2579-88 [16081832.001]
  • [Cites] Rheumatology (Oxford). 2005 Sep;44(9):1140-4 [15927997.001]
  • [Cites] Curr Rheumatol Rep. 2005 Oct;7(5):382-8 [16174489.001]
  • [Cites] J Autoimmun. 2005;25 Suppl:26-8 [16260118.001]
  • [Cites] Cell Immunol. 2005 Jul-Aug;236(1-2):110-4 [16185674.001]
  • [Cites] J Immunol. 2006 Jan 1;176(1):75-84 [16365398.001]
  • [Cites] Arthritis Rheum. 2006 Mar;54(3):765-78 [16508941.001]
  • [Cites] Histol Histopathol. 2007 May;22(5):581-6 [17330813.001]
  • [Cites] Curr Opin Rheumatol. 2007 May;19(3):289-95 [17414958.001]
  • [Cites] Methods. 2007 Nov;43(3):207-17 [17920517.001]
  • [Cites] Annu Rev Pathol. 2006;1:297-329 [18039117.001]
  • [Cites] Annu Rev Pharmacol Toxicol. 2008;48:171-97 [17883327.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1920-7 [18723831.001]
  • [Cites] Mol Cell Biochem. 2010 Feb;335(1-2):283-9 [19784811.001]
  • [Cites] Expert Opin Investig Drugs. 2010 Mar;19(3):345-55 [20113217.001]
  • [Cites] J Exp Med. 1999 Nov 1;190(9):1241-56 [10544196.001]
  • (PMID = 20738854.001).
  • [ISSN] 1478-6362
  • [Journal-full-title] Arthritis research & therapy
  • [ISO-abbreviation] Arthritis Res. Ther.
  • [Language] eng
  • [Grant] United Kingdom / Arthritis Research UK / / 16390; United Kingdom / Arthritis Research UK / / 18547; United Kingdom / Medical Research Council / / G9818340; United Kingdom / Arthritis Research UK / / 20088; United Kingdom / Wellcome Trust / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / CC chemokine receptor 9; 0 / CCL25 protein, human; 0 / Chemokines, CC; 0 / Receptors, CCR; 0 / Tumor Necrosis Factor-alpha
  • [Other-IDs] NLM/ PMC2945064
  •  go-up   go-down


19. Kobayashi H, Yazlovitskaya EM, Lin PC: Interleukin-32 positively regulates radiation-induced vascular inflammation. Int J Radiat Oncol Biol Phys; 2009 Aug 1;74(5):1573-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Expression of cell adhesion molecules and leukocyte adhesion to endothelial cells using human acute monocytic leukemia cell line (THP-1) cells was also analyzed.

  • MedlinePlus Health Information. consumer health - Vasculitis.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Eur Cytokine Netw. 2005 Dec;16(4):289-92 [16464743.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16309-14 [16260731.001]
  • [Cites] Biochim Biophys Acta. 2006 Nov;1761(11):1335-43 [17052951.001]
  • [Cites] Arthritis Res Ther. 2006;8(6):R166 [17078892.001]
  • [Cites] Clin Exp Immunol. 2007 Sep;149(3):480-6 [17590175.001]
  • [Cites] Cell Death Differ. 2008 Oct;15(10):1641-53 [18566601.001]
  • [Cites] Nat Immunol. 2000 Jul;1(1):42-6 [10881173.001]
  • [Cites] J Exp Med. 2003 May 19;197(10):1297-302 [12743172.001]
  • [Cites] Prostaglandins. 1983 Feb;25(2):263-79 [6407068.001]
  • [Cites] Prostaglandins. 1983 Jun;25(6):783-91 [6414049.001]
  • [Cites] Radiat Res. 1986 May;106(2):171-81 [3517934.001]
  • [Cites] Prostaglandins. 1987 Aug;34(2):241-55 [3313528.001]
  • [Cites] Proc Natl Acad Sci U S A. 1990 Oct;87(19):7708-12 [2217203.001]
  • [Cites] Chest. 1997 Apr;111(4):1061-76 [9106589.001]
  • [Cites] Cancer Res. 1997 Jun 1;57(11):2096-9 [9187101.001]
  • [Cites] Nature. 1997 Dec 11;390(6660):622-5 [9403693.001]
  • [Cites] J Immunol. 1998 Jan 1;160(1):410-8 [9551998.001]
  • [Cites] Cancer Res. 1998 Dec 1;58(23):5484-8 [9850083.001]
  • [Cites] J Am Soc Nephrol. 1999 Feb;10(2):404-12 [10215342.001]
  • [Cites] Immunity. 2005 Jan;22(1):131-42 [15664165.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3298-303 [16492735.001]
  • (PMID = 19616744.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA108856; United States / NIAMS NIH HHS / AR / R01 AR053718; United States / NINDS NIH HHS / NS / NS45888; United States / NIAMS NIH HHS / AR / R01 AR053718-03; United States / NCI NIH HHS / CA / R01 CA108856-05; United States / NINDS NIH HHS / NS / R01 NS045888-04; United States / NCI NIH HHS / CA / CA108856-05; United States / NINDS NIH HHS / NS / R01 NS045888; United States / NCI NIH HHS / CA / 5T32CA093240; United States / NIAMS NIH HHS / AR / AR053718-03; United States / NINDS NIH HHS / NS / NS045888-04; United States / NIAMS NIH HHS / AR / AR053718; United States / NCI NIH HHS / CA / CA108856; United States / NCI NIH HHS / CA / T32 CA093240
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cell Adhesion Molecules; 0 / Cyclooxygenase 2 Inhibitors; 0 / IL32 protein, human; 0 / Interleukins; 0 / NF-kappa B; 0 / Vascular Cell Adhesion Molecule-1; 0 / Vascular Endothelial Growth Factor A; EC 1.14.99.1 / Cyclooxygenase 2; EC 3.1.1.4 / Group IV Phospholipases A2; EC 3.4.21.- / PCSK7 protein, human; EC 3.4.21.- / Subtilisins
  • [Other-IDs] NLM/ NIHMS114038; NLM/ PMC2713876
  •  go-up   go-down


20. Li L, Wang J, Ye RD, Shi G, Jin H, Tang X, Yi J: PML/RARalpha fusion protein mediates the unique sensitivity to arsenic cytotoxicity in acute promyelocytic leukemia cells: Mechanisms involve the impairment of cAMP signaling and the aberrant regulation of NADPH oxidase. J Cell Physiol; 2008 Nov;217(2):486-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] PML/RARalpha fusion protein mediates the unique sensitivity to arsenic cytotoxicity in acute promyelocytic leukemia cells: Mechanisms involve the impairment of cAMP signaling and the aberrant regulation of NADPH oxidase.
  • Acute promyelocytic leukemia (APL) cells are characterized by PML/RARalpha fusion protein, high responsiveness to arsenic trioxide (ATO)-induced cytotoxicity and an abundant generation of reactive oxygen species (ROS).
  • We found that NADPH oxidase-derived ROS generation was more abundant in NB4 cells compared with monocytic leukemia U937 cells.
  • [MeSH-major] Antineoplastic Agents / pharmacology. Apoptosis / drug effects. Arsenicals / pharmacology. Cyclic AMP / metabolism. Leukemia, Promyelocytic, Acute / enzymology. NADPH Oxidase / metabolism. Oncogene Proteins, Fusion / metabolism. Oxides / pharmacology. Signal Transduction / drug effects

  • Genetic Alliance. consumer health - Acute Promyelocytic Leukemia.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. ARSENIC TRIOXIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 Wiley-Liss, Inc
  • (PMID = 18636556.001).
  • [ISSN] 1097-4652
  • [Journal-full-title] Journal of cellular physiology
  • [ISO-abbreviation] J. Cell. Physiol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Arsenicals; 0 / Oncogene Proteins, Fusion; 0 / Oxides; 0 / Reactive Oxygen Species; 0 / promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein; E0399OZS9N / Cyclic AMP; EC 1.6.3.1 / NADPH Oxidase; S7V92P67HO / arsenic trioxide
  •  go-up   go-down


21. Rokudai S, Aikawa Y, Tagata Y, Tsuchida N, Taya Y, Kitabayashi I: Monocytic leukemia zinc finger (MOZ) interacts with p53 to induce p21 expression and cell-cycle arrest. J Biol Chem; 2009 Jan 2;284(1):237-44
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Monocytic leukemia zinc finger (MOZ) interacts with p53 to induce p21 expression and cell-cycle arrest.
  • Here we show that monocytic leukemia zinc finger (MOZ) forms a complex with p53 to induce p21 expression and cell-cycle arrest.
  • The leukemia-associated MOZ-CBP fusion protein inhibits p53-mediated transcription.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19001415.001).
  • [ISSN] 0021-9258
  • [Journal-full-title] The Journal of biological chemistry
  • [ISO-abbreviation] J. Biol. Chem.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CDKN1A protein, human; 0 / Cdkn1a protein, mouse; 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / Recombinant Fusion Proteins; 0 / TP53 protein, human; 0 / Tumor Suppressor Protein p53; EC 2.3.1.48 / Histone Acetyltransferases; EC 2.3.1.48 / KAT6A protein, human; EC 2.3.1.48 / MOZ protein, mouse
  •  go-up   go-down


22. Hijiya N, Metzger ML, Pounds S, Schmidt JE, Razzouk BI, Rubnitz JE, Howard SC, Nunez CA, Pui CH, Ribeiro RC: Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia. Pediatr Blood Cancer; 2005 Jan;44(1):63-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood acute myelomonocytic or monocytic leukemia.
  • BACKGROUND: Life-threatening pulmonary complications that coincide with cell lysis during early chemotherapy and that mimic systemic inflammatory response syndrome (SIRS) have been reported in patients with acute myeloid leukemia (AML).
  • RESULTS: Of 155 patients, 5 (3 with M4eo and 2 with M5) experienced severe pulmonary complications attributed to tumor lysis, met the criteria for severe SIRS, and showed no clear evidence of infection.
  • Severe SIRS was significantly more common in myelomonocytic or monocytic AML (M4/M4eo/M5) than in other subtypes (P = 0.010) and significantly more common in M4eo than in M4/M5 (P = 0.008).
  • Among 112 cases for which information was available, leukocyte reduction was significantly greater in patients with M4/M4eo/M5 than among others during the first 4 days of chemotherapy (P = 0.015).
  • CONCLUSIONS: Patients with M4/M4eo/M5 AML, especially M4eo, experience life-threatening cardiopulmonary complications of tumor lysis that meet the criteria for severe SIRS.
  • [MeSH-major] Cell Death. Leukemia, Monocytic, Acute / complications. Leukemia, Monocytic, Acute / drug therapy. Leukemia, Myelomonocytic, Acute / complications. Leukemia, Myelomonocytic, Acute / drug therapy. Systemic Inflammatory Response Syndrome / etiology

  • Genetic Alliance. consumer health - Acute Myelomonocytic Leukemia.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2004 Wiley-Liss, Inc.
  • (PMID = 15368547.001).
  • [ISSN] 1545-5009
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / CA-21765
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


23. Wang X, Zheng Y, Xu Y, Ben J, Gao S, Zhu X, Zhuang Y, Yue S, Bai H, Chen Y, Jiang L, Ji Y, Xu Y, Fan L, Sha J, He Z, Chen Q: A novel peptide binding to the cytoplasmic domain of class A scavenger receptor reduces lipid uptake in THP-1 macrophages. Biochim Biophys Acta; 2009 Jan;1791(1):76-83
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The peptide H11 inhibited the binding and uptake of DiI-AcLDL and attenuated lipid accumulation in the differentiated human acute monocytic leukemia cell line (THP-1) macrophages.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19049904.001).
  • [ISSN] 0006-3002
  • [Journal-full-title] Biochimica et biophysica acta
  • [ISO-abbreviation] Biochim. Biophys. Acta
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Peptide Library; 0 / Peptides; 0 / Recombinant Fusion Proteins; 0 / Scavenger Receptors, Class A; EC 2.7.1.24 / Mitogen-Activated Protein Kinase 9
  •  go-up   go-down


24. Ventura F, Pereira T, da Luz Duarte M, Marques H, Pardal F, Brito C: Indeterminate cell histiocytosis in association with acute myeloid leukemia. Dermatol Res Pract; 2010;2010:569345
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Indeterminate cell histiocytosis in association with acute myeloid leukemia.
  • Indeterminate cell histiocytosis (ICH) is a rare proliferative disorder, in which the predominant cells share morphologic and immunophenotypic features from both Langerhans and non-Langerhans cell histiocytosis.
  • Nevertheless, one month after remission, he developed an acute myeloid leukemia of the subtype monocytic leukemia (M5).
  • We present this case because apart of being rare it joins the effectiveness of thalidomide and the association with an acute monocytic leukemia.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Int J Biochem Cell Biol. 2007;39(7-8):1489-99 [17369076.001]
  • [Cites] Br J Dermatol. 2007 Jun;156(6):1357-61 [17459045.001]
  • [Cites] J Am Acad Dermatol. 2007 Feb;56(2):302-16 [17097374.001]
  • [Cites] J Cutan Pathol. 2005 Sep;32(8):552-60 [16115054.001]
  • [Cites] J Am Acad Dermatol. 1986 Oct;15(4 Pt 1):591-7 [3095403.001]
  • [Cites] Eur J Haematol. 2005 Feb;74(2):172-4 [15654911.001]
  • [Cites] Ann N Y Acad Sci. 1999 Apr 30;872:256-62; discussion 262-4 [10372128.001]
  • [Cites] Br J Dermatol. 1996 Mar;134(3):525-32 [8731682.001]
  • [Cites] Br J Dermatol. 2005 Jul;153(1):206-7 [16029353.001]
  • (PMID = 20672000.001).
  • [ISSN] 1687-6113
  • [Journal-full-title] Dermatology research and practice
  • [ISO-abbreviation] Dermatol Res Pract
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Egypt
  • [Other-IDs] NLM/ PMC2905718
  •  go-up   go-down


25. Kusari S, Zühlke S, Kosuth J, Cellárová E, Spiteller M: Light-independent metabolomics of endophytic Thielavia subthermophila provides insight into microbial hypericin biosynthesis. J Nat Prod; 2009 Oct;72(10):1825-35
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The endophytic metabolites exhibited photodynamic cytotoxicity against the human acute monocytic leukemia cell line (THP-1), at 92.7 vs 4.9%, and 91.1 vs 1.0% viability by resazurin and ATPlite assays, in light and in the dark, respectively.

  • Hazardous Substances Data Bank. PERYLENE .
  • Hazardous Substances Data Bank. EMODIN .
  • SILVA. SILVA LSU Database .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19746917.001).
  • [ISSN] 1520-6025
  • [Journal-full-title] Journal of natural products
  • [ISO-abbreviation] J. Nat. Prod.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 5QD5427UN7 / Perylene; 7V2F1075HD / hypericin; KA46RNI6HN / Emodin
  •  go-up   go-down


26. Zhang GS, Peng HL, Dai CW, Gong FJ, Xu YX, Xiao L, Pei MF, Shen JK, Yang JJ: [Acute monocytic leukemia after orthotopic liver transplantation: clinical features, molecular genetics, and significance thereof]. Zhonghua Yi Xue Za Zhi; 2005 Dec 28;85(49):3504-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Acute monocytic leukemia after orthotopic liver transplantation: clinical features, molecular genetics, and significance thereof].
  • OBJECTIVE: To study the clinical features and molecular genetics of acute monocytic leukemia (AML) after orthotopic liver transplantation and significance thereof.
  • The diagnosis of chronic myelomonocytic leukemia was made.
  • CONCLUSION: Orthotopic liver transplantation may be complicated with acute leukemia heterogeneous in clinical features and hematology.
  • [MeSH-major] Leukemia, Monocytic, Acute / etiology. Leukemia, Monocytic, Acute / genetics. Liver Transplantation / adverse effects. Postoperative Complications

  • Genetic Alliance. consumer health - Transplantation.
  • MedlinePlus Health Information. consumer health - After Surgery.
  • MedlinePlus Health Information. consumer health - Liver Transplantation.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16686070.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / HSP70 Heat-Shock Proteins; EC 2.7.10.1 / FLT3 protein, human; EC 2.7.10.1 / fms-Like Tyrosine Kinase 3; EC 2.7.11.1 / PIM1 protein, human; EC 2.7.11.1 / Proto-Oncogene Proteins c-pim-1
  •  go-up   go-down


27. Yang XJ, Ullah M: MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells. Oncogene; 2007 Aug 13;26(37):5408-19
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Genes of the human monocytic leukemia zinc-finger protein MOZ (HUGO symbol, MYST3) and its paralog MORF (MYST4) are rearranged in chromosome translocations associated with acute myeloid leukemia and/or benign uterine leiomyomata.
  • Although leukemia-derived fusion proteins such as MOZ-TIF2 promote self-renewal of leukemic stem cells, recent studies indicate that murine MOZ and MORF are important for proper development of hematopoietic and neurogenic progenitors, respectively, thereby highlighting the importance of epigenetic integrity in safeguarding stem cell identity.

  • Genetics Home Reference. consumer health - KAT6B gene.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17694082.001).
  • [ISSN] 0950-9232
  • [Journal-full-title] Oncogene
  • [ISO-abbreviation] Oncogene
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Protein Subunits; 0 / Trans-Activators; EC 2.3.1.48 / Histone Acetyltransferases; EC 2.3.1.48 / KAT6A protein, human; EC 2.3.1.48 / KAT6B protein, human
  • [Number-of-references] 106
  •  go-up   go-down


28. Arias F, Vives R, Gómez-Dorronsoro ML: Cutaneous nodes in a patient with advanced papillary carcinoma of the thyroid. Clin Transl Oncol; 2006 Sep;8(9):692-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Leukemia as a second malignancy after treatment of thyroid cancer is also rare.
  • Our patient is unusual in that she showed multisystem involvement at the time of hospital admission, and the specific skin lesions were the first sign of her acute monocytic leukemia.
  • [MeSH-major] Carcinoma, Papillary / radiotherapy. Leukemia, Monocytic, Acute / diagnosis. Leukemia, Radiation-Induced / diagnosis. Neoplasms, Second Primary / diagnosis. Skin Neoplasms / diagnosis. Thyroid Neoplasms / radiotherapy

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Dermatology. 1999;199(4):349-52 [10640848.001]
  • [Cites] Ann Hematol. 1998 Jun;76(6):271-2 [9692815.001]
  • [Cites] Semin Dermatol. 1994 Sep;13(3):223-30 [7986692.001]
  • [Cites] J Am Acad Dermatol. 1997 Apr;36(4):531-7 [9092737.001]
  • [Cites] Br J Haematol. 1988 Jun;69(2):247-52 [3291931.001]
  • [Cites] J Am Acad Dermatol. 1993 May;28(5 Pt 2):884-8 [8491887.001]
  • [Cites] N Engl J Med. 1999 Mar 18;340(11):893-4 [10084909.001]
  • (PMID = 17005473.001).
  • [ISSN] 1699-048X
  • [Journal-full-title] Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
  • [ISO-abbreviation] Clin Transl Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


29. Liu LB, Li L, Xiao J, Zou P: Comparison of immunophenotype and clinical manifestations between patients with M5a and M5b of acute monocytic leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec;14(6):1079-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison of immunophenotype and clinical manifestations between patients with M5a and M5b of acute monocytic leukemia.
  • Acute monocytic leukemia is a distinct subtype of acute myeloid leukemia (AML) with characteristic biology and clinical features.
  • The results showed that the immunophenotypes of monocytic leukemic cells in patients with AML M(5) were heterogeneous, and CD68 and CD11b were expressed higher in patients with AML M(5a), compared with that in patients with AML M(5b) (P < 0.01).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17204168.001).
  • [ISSN] 1009-2137
  • [Journal-full-title] Zhongguo shi yan xue ye xue za zhi
  • [ISO-abbreviation] Zhongguo Shi Yan Xue Ye Xue Za Zhi
  • [Language] ENG
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, CD11b; 0 / Antigens, Differentiation, Myelomonocytic; 0 / CD68 antigen, human
  •  go-up   go-down


30. Ferreira M, Caetano M, Amorim I, Selores M: Leukemia cutis resembling a flare-up of psoriasis. Dermatol Online J; 2006;12(3):13
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leukemia cutis resembling a flare-up of psoriasis.
  • Leukemia cutis represents a skin infiltration by leukemic cells.
  • Studies of peripheral blood and bone marrow provided a diagnosis of acute monocytic leukemia.
  • This case report shows the importance of the clinical suspicion for the diagnosis of leukemia.
  • [MeSH-major] Leukemia, Monocytic, Acute / diagnosis. Psoriasis / diagnosis

  • Genetic Alliance. consumer health - Psoriasis.
  • MedlinePlus Health Information. consumer health - Psoriasis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16638427.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


31. Sturm B, Helminger M, Steinkellner H, Heidari MM, Goldenberg H, Scheiber-Mojdehkar B: Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor. Eur J Clin Invest; 2010 Jun;40(6):561-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Friedreich's ataxia (FRDA) is a neurodegenerative disorder caused by decreased expression of the mitochondrial protein frataxin.
  • MATERIALS AND METHODS: In our experiments human erythroleukaemic K562 cells (+ EPO-R), human monocytic leukemia THP-1 cells (- EPO-R) and isolated primary lymphocytes from healthy control and FRDA patients were incubated with different concentrations of rhuEPO or CEPO.

  • MedlinePlus Health Information. consumer health - Friedreich's Ataxia.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20456483.001).
  • [ISSN] 1365-2362
  • [Journal-full-title] European journal of clinical investigation
  • [ISO-abbreviation] Eur. J. Clin. Invest.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Iron-Binding Proteins; 0 / Recombinant Proteins; 0 / carbamylated erythropoietin; 0 / frataxin; 11096-26-7 / Erythropoietin
  •  go-up   go-down


32. Masurier C, Boutin S, Veron P, Bernard J, Danos O, Davoust J: Enhanced lentiviral transduction of monocyte-derived dendritic cells in the presence of conditioned medium from dying monocytes. Hum Gene Ther; 2007 Feb;18(2):161-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This enhanced transduction efficiency requires the presence of MCM during the initial stage of LV transduction and does not affect the phenotype and antigen presentation function of terminally differentiated Mo-DCs.
  • Importantly, we found that MCM derived from a human acute monocytic leukemia cell line, THP-1, was equally effective.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17326725.001).
  • [ISSN] 1043-0342
  • [Journal-full-title] Human gene therapy
  • [ISO-abbreviation] Hum. Gene Ther.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Culture Media, Conditioned
  •  go-up   go-down


33. Qian B, Sun Z, Wu Z, Liu H, Wang X, Zhai Z: A novel translocation, t(3;20)(q13;p13), in acute monocytic leukemia. Cancer Genet Cytogenet; 2009 Jan 1;188(1):52-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A novel translocation, t(3;20)(q13;p13), in acute monocytic leukemia.
  • [MeSH-major] Chromosomes, Human, Pair 20 / genetics. Chromosomes, Human, Pair 3 / genetics. Leukemia, Monocytic, Acute / genetics. Translocation, Genetic

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19061781.001).
  • [ISSN] 1873-4456
  • [Journal-full-title] Cancer genetics and cytogenetics
  • [ISO-abbreviation] Cancer Genet. Cytogenet.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  •  go-up   go-down


34. Hahn M, Li W, Yu C, Rahmani M, Dent P, Grant S: Rapamycin and UCN-01 synergistically induce apoptosis in human leukemia cells through a process that is regulated by the Raf-1/MEK/ERK, Akt, and JNK signal transduction pathways. Mol Cancer Ther; 2005 Mar;4(3):457-70
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rapamycin and UCN-01 synergistically induce apoptosis in human leukemia cells through a process that is regulated by the Raf-1/MEK/ERK, Akt, and JNK signal transduction pathways.
  • Interactions between the protein kinase C and Chk1 inhibitor UCN-01 and rapamycin in human leukemia cells have been investigated in relation to apoptosis induction.
  • Treatment of U937 monocytic leukemia cells with rapamycin (10 nmol/L) in conjunction with a minimally toxic concentration of UCN-01 (100 nmol/L) for 36 hours resulted in marked potentiation of mitochondrial injury (i.e., loss of mitochondrial membrane potential and cytosolic release of cytochrome c, AIF, and Smac/DIABLO), caspase activation, and apoptosis.
  • Together, these findings indicate that the mammalian target of rapamycin inhibitor potentiates UCN-01 cytotoxicity in a variety of human leukemia cell types and suggest that inhibition of both Raf-1/MEK/ERK and Akt cytoprotective signaling pathways as well as JNK activation contribute to this phenomenon.
  • [MeSH-major] Apoptosis. Extracellular Signal-Regulated MAP Kinases / metabolism. JNK Mitogen-Activated Protein Kinases / metabolism. Leukemia / drug therapy. MAP Kinase Kinase 1 / metabolism. Mitogen-Activated Protein Kinase Kinases / metabolism. Protein-Serine-Threonine Kinases / metabolism. Proto-Oncogene Proteins / metabolism. Proto-Oncogene Proteins c-raf / metabolism. Sirolimus / pharmacology. Staurosporine / analogs & derivatives. Staurosporine / pharmacology


35. Cheng KC, Huang HC, Chen JH, Hsu JW, Cheng HC, Ou CH, Yang WB, Chen ST, Wong CH, Juan HF: Ganoderma lucidum polysaccharides in human monocytic leukemia cells: from gene expression to network construction. BMC Genomics; 2007;8:411
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ganoderma lucidum polysaccharides in human monocytic leukemia cells: from gene expression to network construction.
  • This gave rise to our investigation on how F3 stimulates immuno-modulating or anti-tumor effects in human leukemia THP-1 cells.
  • [MeSH-minor] Blotting, Western. Cell Line, Tumor. Cytokines / genetics. Cytokines / metabolism. Enzyme-Linked Immunosorbent Assay. Gene Expression Profiling. Humans. Leukemia, Monocytic, Acute / genetics. Leukemia, Monocytic, Acute / metabolism. Leukemia, Monocytic, Acute / pathology. Oligonucleotide Array Sequence Analysis. Plant Extracts / chemistry. Plant Extracts / pharmacology. Polymerase Chain Reaction. Receptors, Death Domain / genetics. Receptors, Death Domain / metabolism. Signal Transduction / drug effects. Signal Transduction / genetics. Signal Transduction / physiology

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nature. 1999 Nov 4;402(6757):86-90 [10573422.001]
  • [Cites] Leuk Res. 2006 Jul;30(7):841-8 [16423392.001]
  • [Cites] Nature. 2000 Jun 15;405(6788):823-6 [10866208.001]
  • [Cites] Nat Cell Biol. 2001 Apr;3(4):409-16 [11283615.001]
  • [Cites] J Biol Chem. 2001 Jan 26;276(4):2668-77 [11035039.001]
  • [Cites] Oncogene. 2001 Oct 4;20(45):6617-26 [11641787.001]
  • [Cites] Bioorg Med Chem. 2002 Apr;10(4):1057-62 [11836115.001]
  • [Cites] Cell Signal. 2002 Jun;14(6):477-92 [11897488.001]
  • [Cites] Nature. 2002 May 23;417(6887):399-403 [12000970.001]
  • [Cites] J Clin Immunol. 2002 Jul;22(4):185-94 [12148593.001]
  • [Cites] Electrophoresis. 2002 Aug;23(15):2490-504 [12210208.001]
  • [Cites] Int J Cancer. 2002 Nov 20;102(3):250-3 [12397644.001]
  • [Cites] Nat Rev Immunol. 2002 Nov;2(11):881-9 [12415311.001]
  • [Cites] Annu Rev Immunol. 2003;21:335-76 [12524386.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2003 Apr;284(4):L663-70 [12495940.001]
  • [Cites] Cell Death Differ. 2003 Jan;10(1):45-65 [12655295.001]
  • [Cites] Cell Death Differ. 2003 Jan;10(1):66-75 [12655296.001]
  • [Cites] J Immunol. 2003 Aug 15;171(4):1941-9 [12902497.001]
  • [Cites] Cell Cycle. 2003 Nov-Dec;2(6):550-2 [14504472.001]
  • [Cites] Anal Chem. 2003 Nov 15;75(22):6163-70 [14615996.001]
  • [Cites] Leuk Res. 2004 Jan;28(1):63-9 [14630082.001]
  • [Cites] J Altern Complement Med. 2006 Oct;12(8):777-89 [17034284.001]
  • [Cites] Biochem Biophys Res Commun. 2006 Nov 24;350(3):736-41 [17027647.001]
  • [Cites] Oncol Rep. 2006 Dec;16(6):1181-7 [17089035.001]
  • [Cites] Oncol Rep. 2006 Dec;16(6):1313-6 [17089055.001]
  • [Cites] Life Sci. 2006 Dec 23;80(3):205-11 [17007887.001]
  • [Cites] Cancer Lett. 2007 Feb 8;246(1-2):210-7 [16574319.001]
  • [Cites] Leuk Res. 2007 Apr;31(4):455-63 [16920192.001]
  • [Cites] Ann N Y Acad Sci. 2006 Dec;1090:209-16 [17384264.001]
  • [Cites] Cancer Res. 2007 May 1;67(9):4443-50 [17483359.001]
  • [Cites] Int J Oncol. 2004 May;24(5):1093-9 [15067330.001]
  • [Cites] Bioinformatics. 2004 Jun 12;20(9):1453-4 [14871861.001]
  • [Cites] Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W460-4 [15215430.001]
  • [Cites] Bioorg Med Chem. 2004 Nov 1;12(21):5595-601 [15465337.001]
  • [Cites] Phytother Res. 2004 Sep;18(9):768-70 [15478180.001]
  • [Cites] Cancer Lett. 2004 Dec 8;216(1):9-20 [15500944.001]
  • [Cites] Cell. 1994 Mar 25;76(6):959-62 [8137429.001]
  • [Cites] Blood. 1994 Apr 15;83(8):2045-56 [8161776.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 May 26;95(11):5849-56 [9600883.001]
  • [Cites] Science. 1998 Aug 28;281(5381):1305-8 [9721089.001]
  • [Cites] Trends Biochem Sci. 1998 Sep;23(9):324-8 [9787636.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):2896-901 [10077608.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4285-8 [10200254.001]
  • [Cites] Curr Opin Cell Biol. 1999 Apr;11(2):255-60 [10209153.001]
  • [Cites] Science. 1999 Jul 30;285(5428):751-3 [10427000.001]
  • [Cites] J Immunol. 2004 Nov 15;173(10):5989-99 [15528333.001]
  • [Cites] Mini Rev Med Chem. 2004 Oct;4(8):873-9 [15544548.001]
  • [Cites] Apoptosis. 2005 Jan;10(1):35-51 [15711921.001]
  • [Cites] Cancer Lett. 2005 Mar 18;220(1):21-8 [15737684.001]
  • [Cites] Genome Biol. 2005;6(3):211 [15774034.001]
  • [Cites] Biochem Biophys Res Commun. 2005 Apr 29;330(1):46-52 [15781230.001]
  • [Cites] Bioinformatics. 2005 Apr 1;21(7):1180-8 [15513993.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12837-42 [16141318.001]
  • [Cites] Cancer Res. 2005 Nov 15;65(22):10214-22 [16288009.001]
  • [Cites] J Clin Oncol. 2006 Jan 10;24(2):274-87 [16365179.001]
  • [Cites] Nature. 2006 Jan 19;439(7074):353-7 [16273092.001]
  • [Cites] Exp Oncol. 2006 Mar;28(1):25-9 [16614703.001]
  • [Cites] J Biol Chem. 2006 Aug 25;281(34):24111-23 [16798741.001]
  • [Cites] Nat Genet. 2000 May;25(1):25-9 [10802651.001]
  • (PMID = 17996095.001).
  • [ISSN] 1471-2164
  • [Journal-full-title] BMC genomics
  • [ISO-abbreviation] BMC Genomics
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cytokines; 0 / Drugs, Chinese Herbal; 0 / Plant Extracts; 0 / Polysaccharides; 0 / Receptors, Death Domain
  • [Other-IDs] NLM/ PMC2211495
  •  go-up   go-down


36. Liu JJ, Zhang Y, Guang WB, Yang HZ, Lin DJ, Xiao RZ: Ponicidin inhibits monocytic leukemia cell growth by induction of apoptosis. Int J Mol Sci; 2008 Nov;9(11):2265-77
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ponicidin inhibits monocytic leukemia cell growth by induction of apoptosis.
  • In this study two monocytic leukemia cell lines, U937 and THP-1 cells, were used to investigate the anti-proliferation effects caused by ponicidin.
  • We therefore conclude that ponicidin has significant anti-proliferation effects by inducing apoptosis on leukemia cells in vitro, downregulation of survivin as well as Bcl-2 expressions may be the important apoptosis inducing mechanisms.
  • The results suggest that ponicidin may serve as potential therapeutic agent for leukemia.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Leuk Res. 2007 Nov;31(11):1495-501 [17328950.001]
  • [Cites] Clin Cancer Res. 2000 Jan;6(1):127-34 [10656440.001]
  • [Cites] Int J Hematol. 2004 Oct;80(3):232-8 [15540897.001]
  • [Cites] Cancer Res. 1998 Nov 15;58(22):5071-4 [9823313.001]
  • [Cites] Cancer Res. 1998 May 1;58(9):1808-12 [9581817.001]
  • [Cites] Lancet. 1998 Mar 21;351(9106):882-3 [9525374.001]
  • [Cites] Phytochemistry. 1994 Jul;36(5):1287-91 [7765366.001]
  • [Cites] Semin Surg Oncol. 2003;21(2):122-7 [14508862.001]
  • [Cites] Biochim Biophys Acta. 2004 Mar 1;1644(2-3):229-49 [14996506.001]
  • [Cites] Cancer Immunol Immunother. 2004 Mar;53(3):153-9 [14749900.001]
  • [Cites] Biochem Biophys Res Commun. 2004 Feb 13;314(3):902-7 [14741722.001]
  • [Cites] J Nat Prod. 2004 Jan;67(1):2-4 [14738375.001]
  • [Cites] J Thorac Cardiovasc Surg. 2003 Oct;126(4):1141-6 [14566260.001]
  • [Cites] Cancer Biol Ther. 2003 Jul-Aug;2(4 Suppl 1):S105-14 [14508087.001]
  • [Cites] Chem Pharm Bull (Tokyo). 2003 Jul;51(7):790-3 [12843583.001]
  • [Cites] Fitoterapia. 2003 Jul;74(5):435-8 [12837357.001]
  • [Cites] Cancer Sci. 2003 Jan;94(1):15-21 [12708468.001]
  • [Cites] Leuk Lymphoma. 2002 Dec;43(12):2249-55 [12613509.001]
  • [Cites] Haematologica. 2003 Feb;88(2):212-8 [12604411.001]
  • [Cites] Cancer Chemother Pharmacol. 2002 Nov;50(5):343-52 [12439591.001]
  • [Cites] Planta Med. 2002 Oct;68(10):946-8 [12391566.001]
  • [Cites] Hum Gene Ther. 2002 Feb 10;13(3):415-23 [11860708.001]
  • [Cites] Oncogene. 2000 Mar 2;19(10):1346-53 [10713676.001]
  • [Cites] Clin Cancer Res. 2007 Oct 15;13(20):5991-4 [17947459.001]
  • (PMID = 19330074.001).
  • [ISSN] 1422-0067
  • [Journal-full-title] International journal of molecular sciences
  • [ISO-abbreviation] Int J Mol Sci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Other-IDs] NLM/ PMC2635634
  • [Keywords] NOTNLM ; Bax / Bcl-2 / Leukemia / Ponicidin / Survivin
  •  go-up   go-down


37. Janic B, Rad AM, Jordan EK, Iskander AS, Ali MM, Varma NR, Frank JA, Arbab AS: Optimization and validation of FePro cell labeling method. PLoS One; 2009 Jun 11;4(6):e5873
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Human tumor glioma (U251) and human monocytic leukemia cell (THP-1) lines were used as model systems for attached and suspension cell types, respectively and dose dependent (Fe 25 to 100 microg/ml and Pro 0.75 to 3 microg/ml) and time dependent (2 to 48 h) labeling experiments were performed.

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. Ferumoxides .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Blood. 2004 Aug 15;104(4):1217-23 [15100158.001]
  • [Cites] Magn Reson Med. 2003 Jun;49(6):1006-13 [12768577.001]
  • [Cites] Radiology. 2005 Apr;235(1):155-61 [15749976.001]
  • [Cites] NMR Biomed. 2005 Oct;18(6):383-9 [16013087.001]
  • [Cites] Bioconjug Chem. 2005 Sep-Oct;16(5):1240-5 [16173804.001]
  • [Cites] Mol Imaging. 2005 Jul-Sep;4(3):165-71 [16194448.001]
  • [Cites] NMR Biomed. 2005 Dec;18(8):553-9 [16229060.001]
  • [Cites] NMR Biomed. 2006 Aug;19(5):581-92 [16673357.001]
  • [Cites] Mol Imaging. 2007 Jan-Feb;6(1):1-9 [17311760.001]
  • [Cites] Nat Protoc. 2006;1(1):73-9 [17406214.001]
  • [Cites] J Magn Reson Imaging. 2007 Aug;26(2):366-74 [17623892.001]
  • [Cites] Biotechniques. 2007 Nov;43(5):627-8, 630, 632 passim [18072592.001]
  • [Cites] Stem Cells. 2008 May;26(5):1366-75 [18276802.001]
  • [Cites] FASEB J. 2008 Sep;22(9):3234-46 [18556461.001]
  • [Cites] Nat Biotechnol. 2000 Apr;18(4):410-4 [10748521.001]
  • [Cites] J Immunol Methods. 2001 Oct 1;256(1-2):89-105 [11516758.001]
  • [Cites] AJR Am J Roentgenol. 1990 Nov;155(5):943-50 [2120963.001]
  • (PMID = 19517015.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA 122031; United States / NCI NIH HHS / CA / R21 CA129801; United States / Intramural NIH HHS / / ; United States / NINDS NIH HHS / NS / R21 NS058589; United States / NCI NIH HHS / CA / R01 CA122031; United States / NCI NIH HHS / CA / R21 CA 129801; United States / NINDS NIH HHS / NS / R21 NS 058589
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / AC133 antigen; 0 / Antigens, CD; 0 / Antigens, CD3; 0 / Contrast Media; 0 / Glycoproteins; 0 / Magnetite Nanoparticles; 0 / Peptides; 0 / Protamines; G6N3J05W84 / ferumoxides; K3R6ZDH4DU / Dextrans; XM0M87F357 / Ferrosoferric Oxide
  • [Other-IDs] NLM/ PMC2690694
  •  go-up   go-down


38. Chantrain CF, Sauvage D, Brichard B, Dupont S, Poirel HA, Ameye G, De Weer A, Vandenberghe P, Detaille T, Anslot C, de Cléty SC, Vermylen C: Neonatal acute myeloid leukemia in an infant whose mother was exposed to diethylstilboestrol in utero. Pediatr Blood Cancer; 2009 Aug;53(2):220-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Neonatal acute myeloid leukemia in an infant whose mother was exposed to diethylstilboestrol in utero.
  • We report on an acute myeloid leukemia in a neonate whose mother was exposed to diethylstilboestrol in utero.
  • The newborn presented with leukemia cutis, hemorrhagic skin lesions, hyperleucocytosis and disseminated intravascular coagulation.
  • A bone marrow examination confirmed the diagnosis of acute monocytic leukemia with a t(11;19) MLL-ELL fusion transcript.
  • This case shows acute myeloid leukemia and the third pediatric leukemia reported after maternal diethylstilboestrol exposure.
  • [MeSH-major] Diethylstilbestrol / adverse effects. Estrogens, Non-Steroidal / adverse effects. Leukemia, Myeloid, Acute / chemically induced. Prenatal Exposure Delayed Effects / chemically induced
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Female. Humans. In Situ Hybridization, Fluorescence. Infant, Newborn. Infertility, Female / chemically induced. Male. Mothers. Myeloid-Lymphoid Leukemia Protein. Oncogene Proteins, Fusion. Pedigree. Pregnancy. Reverse Transcriptase Polymerase Chain Reaction

  • Genetic Alliance. consumer health - Leukemia, Myeloid.
  • MedlinePlus Health Information. consumer health - Acute Myeloid Leukemia.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. DIETHYLSTILBESTROL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2009 Wiley-Liss, Inc.
  • (PMID = 19405140.001).
  • [ISSN] 1545-5017
  • [Journal-full-title] Pediatric blood & cancer
  • [ISO-abbreviation] Pediatr Blood Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Estrogens, Non-Steroidal; 0 / MLL-ELL fusion protein, human; 0 / Oncogene Proteins, Fusion; 149025-06-9 / Myeloid-Lymphoid Leukemia Protein; 731DCA35BT / Diethylstilbestrol
  •  go-up   go-down


39. Wang CL, Chen ZX, Li ZJ, Cen JN: [Effect of TIMP-2, MT1-MMP and MMP-2 expression on the in vitro invasive capacity of acute monocytic leukemia SHI-1 cells]. Zhonghua Xue Ye Xue Za Zhi; 2010 Dec;31(12):798-803
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Effect of TIMP-2, MT1-MMP and MMP-2 expression on the in vitro invasive capacity of acute monocytic leukemia SHI-1 cells].
  • OBJECTIVE: To study the effect of matrix metalloproteinase 2 (MMP-2), membrane type 1 MMP (MT1-MMP) and tissue inhibitor of metalloproteinase 2 (TIMP-2) expressions on the in vitro invasive capacity of acute monocytic leukemia SHI-1 cells.
  • METHODS: SHI-1, NB4, K562, M937 and THP-1 human leukemia cell lines were cultured in vitro.
  • [MeSH-major] Leukemia, Monocytic, Acute. Matrix Metalloproteinase 2

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21223734.001).
  • [ISSN] 0253-2727
  • [Journal-full-title] Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • [ISO-abbreviation] Zhonghua Xue Ye Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / RNA, Messenger; EC 3.4.24.- / Matrix Metalloproteinases, Membrane-Associated; EC 3.4.24.24 / Matrix Metalloproteinase 2
  •  go-up   go-down


40. Hulot C, Peluso J, Blond G, Muller CD, Suffert J: Synthesis of exotic polycycles such as cyclooctatrienes and fenestrenes with differential pro-apoptotic activities on human TRAIL-resistant metastatic cell lines. Bioorg Med Chem Lett; 2010 Nov 15;20(22):6836-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Among the 20 new compounds tested, two compounds presented specific activities on the colon carcinomas TRAIL-resistant metastatic cell SW620, but a minor action on the monocytic leukemia THP-1 cell line.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Ltd. All rights reserved.
  • (PMID = 20864342.001).
  • [ISSN] 1464-3405
  • [Journal-full-title] Bioorganic & medicinal chemistry letters
  • [ISO-abbreviation] Bioorg. Med. Chem. Lett.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Polycyclic Compounds; 0 / TNF-Related Apoptosis-Inducing Ligand; 0 / TNFSF10 protein, human
  •  go-up   go-down


41. Zhang D, Xu L, Cao F, Wei T, Yang C, Uzan G, Peng B: Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose- and cell type-dependent way. Cell Stress Chaperones; 2010 Nov;15(6):939-46
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, we observe the effects of celastrol on 18 TFs (belonging to HSP90 clients) in three human cell lines: MCF-7 (breast cancer), HepG2 (hepatoma), and THP-1 (monocytic leukemia).

  • antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Blood. 2008 Jun 15;111(12):5654-62 [18305216.001]
  • [Cites] Exp Mol Med. 2007 Dec 31;39(6):715-21 [18160842.001]
  • [Cites] Drug Resist Updat. 2009 Feb-Apr;12(1-2):17-27 [19179103.001]
  • [Cites] Eur J Pharmacol. 2009 Jun 10;612(1-3):131-42 [19356729.001]
  • [Cites] Eur J Pharmacol. 2009 Jun 10;612(1-3):98-105 [19356734.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1217-25 [19545787.001]
  • [Cites] Angew Chem Int Ed Engl. 2009;48(32):5853-5 [19585625.001]
  • [Cites] Eur J Clin Invest. 2009 Sep;39(9):819-27 [19549173.001]
  • [Cites] J Biol Chem. 2009 Sep 18;284(38):25984-92 [19617349.001]
  • [Cites] BMC Neurosci. 2009;10:109 [19723328.001]
  • [Cites] BMC Cancer. 2009;9:343 [19778460.001]
  • [Cites] J Biol Chem. 2009 Dec 18;284(51):35381-9 [19858214.001]
  • [Cites] Neurol Res. 2010 Feb;32(1):94-100 [19909582.001]
  • [Cites] J Biol Chem. 2010 Feb 5;285(6):4224-31 [19996313.001]
  • [Cites] Cancer Res. 2010 Mar 1;70(5):1951-9 [20160026.001]
  • [Cites] J Biol Chem. 2010 Apr 9;285(15):11498-507 [20154087.001]
  • [Cites] Biochem Biophys Res Commun. 2010 Apr 9;394(3):439-42 [20226165.001]
  • [Cites] Cancer Res. 2006 May 1;66(9):4758-65 [16651429.001]
  • [Cites] Prog Neuropsychopharmacol Biol Psychiatry. 2001 Oct;25(7):1341-57 [11513350.001]
  • [Cites] Biosci Biotechnol Biochem. 2003 Sep;67(9):1883-7 [14519971.001]
  • [Cites] Biochem Biophys Res Commun. 2004 Sep 24;322(3):778-86 [15336532.001]
  • [Cites] Genes Dev. 1998 Dec 15;12(24):3788-96 [9869631.001]
  • [Cites] Bioorg Med Chem Lett. 1998 Jul 21;8(14):1883-6 [9873452.001]
  • [Cites] J Biol Chem. 2004 Dec 31;279(53):56053-60 [15509580.001]
  • [Cites] J Leukoc Biol. 2006 Aug;80(2):309-19 [16769766.001]
  • [Cites] Neurodegener Dis. 2005;2(5):246-54 [16909005.001]
  • [Cites] Cancer Cell. 2006 Oct;10(4):321-30 [17010675.001]
  • [Cites] Biochem Pharmacol. 2006 Nov 15;72(10):1311-21 [16984800.001]
  • [Cites] Blood. 2007 Apr 1;109(7):2727-35 [17110449.001]
  • [Cites] Cell Stress Chaperones. 2007 Autumn;12(3):237-44 [17915556.001]
  • [Cites] Mol Biol Cell. 2008 Mar;19(3):1104-12 [18199679.001]
  • [Cites] Mol Cancer Ther. 2008 Jan;7(1):162-70 [18202019.001]
  • [Cites] J Ethnopharmacol. 2009 Jan 12;121(1):61-8 [18996177.001]
  • (PMID = 20480272.001).
  • [ISSN] 1466-1268
  • [Journal-full-title] Cell stress & chaperones
  • [ISO-abbreviation] Cell Stress Chaperones
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / HSP90 Heat-Shock Proteins; 0 / Transcription Factors; 0 / Triterpenes; 34157-83-0 / tripterine
  • [Other-IDs] NLM/ PMC3024068
  •  go-up   go-down


42. Alvarez-Errico D, Sayós J, López-Botet M: The IREM-1 (CD300f) inhibitory receptor associates with the p85alpha subunit of phosphoinositide 3-kinase. J Immunol; 2007 Jan 15;178(2):808-16
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the present study, immunoprecipitation analysis revealed that both the p85alpha subunit of PI3K and Src homology region 2 domain-containing phosphatase-1 could be recruited by IREM-1 in transfected cells as well as in the U937 monocytic leukemia cells, which constitutively express the receptor.
  • By assaying the ability of different IREM-1 mutants to regulate the secretion of beta-hexosaminidase induced via FcRepsilonI in rat basophilic leukemia cells, both Y205 and Y249 appeared crucial for IREM-1-mediated inhibition.
  • Remarkably, engagement of an IREM-1 mutant (Y(205,249,284)F), which did not recruit Src homology region 2 domain-containing phosphatase-1 and lost its inhibitory function, induced rat basophilic leukemia cell degranulation.

  • PhosphoSitePlus. gene/protein/disease-specific - PhosphoSitePlus® - comprehensive post-translational modification resource .
  • Hazardous Substances Data Bank. L-TYROSINE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17202342.001).
  • [ISSN] 0022-1767
  • [Journal-full-title] Journal of immunology (Baltimore, Md. : 1950)
  • [ISO-abbreviation] J. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Surface; 0 / CD300C protein, human; 0 / GRB2 Adaptor Protein; 0 / Membrane Glycoproteins; 0 / Protein Subunits; 0 / Receptors, IgE; 42HK56048U / Tyrosine; EC 2.7.1.- / Phosphatidylinositol 3-Kinases; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt; EC 3.1.3.16 / Protein Phosphatase 1; EC 3.1.3.48 / Protein Tyrosine Phosphatase, Non-Receptor Type 6
  •  go-up   go-down


43. Ru YX, Mi YC, Liu JH, Wang HJ, Zhao SX, Cui W, Li CW, Li QH, Zhu XF, Xiao ZJ, Pang JX, Wang JX: Significance of transmission electron microscopy in subtyping of monocytic leukemia. Ultrastruct Pathol; 2009 Mar-Apr;33(2):67-75
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Significance of transmission electron microscopy in subtyping of monocytic leukemia.
  • The objective of this paper is to produce an ultrastructural classification of acute monocytic leukemia (AML-M5) in relation to clinical behaviors.
  • The ultrastructural characteristics of blasts of the monocytic series were analyzed in 72 M5 patients by transmission electron microscopy (TEM), in terms of their content of typical monoblasts, atypical monoblasts, atypical promonocytes, and typical promonocytes in bone-marrow aspirates.
  • Four kinds of monocytic blasts were identified by cell size and shape, nuclear profile, nucleocytoplasmic ratio, heterochromatin content, nucleolus, granules, vesicles, and Golgi apparatus.
  • The data obtained permitted M5 patients to be divided into monoblast and promonocyte types.
  • Monoblast-type patients expressed weaker monocytic enzymograms and specific antigen staining for CD14 and CD64, compared with promonocyte-type patients.
  • [MeSH-major] Immunophenotyping / methods. Leukemia, Monocytic, Acute / classification. Microscopy, Electron, Transmission / methods. Monocyte-Macrophage Precursor Cells / ultrastructure

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19274583.001).
  • [ISSN] 1521-0758
  • [Journal-full-title] Ultrastructural pathology
  • [ISO-abbreviation] Ultrastruct Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] EC 1.11.1.7 / Peroxidase
  •  go-up   go-down


44. Ge J, Cheng B, He P, Wen H, Lu H, Chen X, Zeng Y: [Construction and identification of recombinant firefly luciferase report vector containing human acyl coenzyme a: cholesterol acyltransferase 1 gene P7 promoter]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Dec;25(6):1381-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The DNA segment of the human acyl coenzyme A: cholesterol acyltransferasel (ACAT1) gene P7 promoter was amplified by PCR from human monocytic leukemia cell line (THP-1) and cloned to TA vector, then the positive clone was confirmed by restriction enzymes and sequencing.
  • [MeSH-minor] Cell Line, Tumor. Chromosomes, Human, Pair 7 / genetics. Gene Expression Regulation. Humans. Leukemia, Monocytic, Acute / pathology. RNA, Messenger / genetics. RNA, Messenger / metabolism. Recombinant Proteins / genetics. Recombinant Proteins / metabolism. Transfection

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19166214.001).
  • [ISSN] 1001-5515
  • [Journal-full-title] Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi
  • [ISO-abbreviation] Sheng Wu Yi Xue Gong Cheng Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / RNA, Messenger; 0 / Recombinant Proteins; EC 1.13.12.7 / Luciferases, Firefly; EC 2.3.1.26 / Sterol O-Acyltransferase; EC 2.3.1.26 / sterol O-acyltransferase 1
  •  go-up   go-down


45. Akan Z, Aksu B, Tulunay A, Bilsel S, Inhan-Garip A: Extremely low-frequency electromagnetic fields affect the immune response of monocyte-derived macrophages to pathogens. Bioelectromagnetics; 2010 Dec;31(8):603-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • THP-1 cells (human monocytic leukemia cell line) were cultured and 50 Hz, 1 mT EMF was applied for 4-6 h to cells induced with Staphylococcus aureus or interferon gamma/lipopolysaccharide (IFγ/LPS).

  • MedlinePlus Health Information. consumer health - Electromagnetic Fields.
  • Hazardous Substances Data Bank. NITRIC OXIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Wiley-Liss, Inc.
  • (PMID = 20809504.001).
  • [ISSN] 1521-186X
  • [Journal-full-title] Bioelectromagnetics
  • [ISO-abbreviation] Bioelectromagnetics
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / HSP70 Heat-Shock Proteins; 31C4KY9ESH / Nitric Oxide; EC 1.14.13.39 / Nitric Oxide Synthase Type II; EC 3.4.22.- / Caspase 9; H2D2X058MU / Cyclic GMP
  •  go-up   go-down


46. Bloise E, Braca A, De Tommasi N, Belisario MA: Pro-apoptotic and cytostatic activity of naturally occurring cardenolides. Cancer Chemother Pharmacol; 2009 Sep;64(4):793-802
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: The pro-apoptotic and cytostatic effect of the compounds was tested in U937 (monocytic leukemia) and PC3 (prostate adenocarcinoma).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19184018.001).
  • [ISSN] 1432-0843
  • [Journal-full-title] Cancer chemotherapy and pharmacology
  • [ISO-abbreviation] Cancer Chemother. Pharmacol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Cardenolides; 0 / DNA Primers; 0 / Enzyme Inhibitors; EC 3.6.3.9 / Sodium-Potassium-Exchanging ATPase
  •  go-up   go-down


47. Thomas T, Corcoran LM, Gugasyan R, Dixon MP, Brodnicki T, Nutt SL, Metcalf D, Voss AK: Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells. Genes Dev; 2006 May 1;20(9):1175-86
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells.
  • Monocytic leukemia zinc finger protein (MOZ), a transcriptional coactivator and member of the MYST family of histone acetyltransferases, is the target of recurrent translocations in acute myeloid leukemia.
  • Since genes associated with translocations in leukemia are typically important regulators of blood formation, we investigated if Moz has a role in normal hematopoiesis.


48. Horny HP, Sotlar K, Valent P: Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: a review. Pathobiology; 2010;77(4):169-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Even more challenging is the recognition of hematological neoplasms with signs of mast cell differentiation but not fulfilling diagnostic criteria for SM, especially the rare myelomastocytic leukemia.
  • This hypogranulation can be regarded as cellular atypia and may lead to the misdiagnosis aspect of monocytic leukemia or histiocytic neoplasm.

  • Genetic Alliance. consumer health - Mast cell disease.
  • Genetic Alliance. consumer health - Systemic mastocytosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20616612.001).
  • [ISSN] 1423-0291
  • [Journal-full-title] Pathobiology : journal of immunopathology, molecular and cellular biology
  • [ISO-abbreviation] Pathobiology
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  •  go-up   go-down


49. Ansa-Addo EA, Lange S, Stratton D, Antwi-Baffour S, Cestari I, Ramirez MI, McCrossan MV, Inal JM: Human plasma membrane-derived vesicles halt proliferation and induce differentiation of THP-1 acute monocytic leukemia cells. J Immunol; 2010 Nov 1;185(9):5236-46
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Human plasma membrane-derived vesicles halt proliferation and induce differentiation of THP-1 acute monocytic leukemia cells.
  • Our in vitro findings support a model in which TGF-β1-bearing PMVs, released from promonocytic leukemia cells (THP-1) or primary peripheral blood monocytes on exposure to sublytic complement or after treatment with a differentiation therapy agent, such as all-trans retinoic acid, significantly reduce proliferation of THP-1 cells.
  • [MeSH-minor] Apoptosis / physiology. Blotting, Western. Cell Line, Tumor. Cell Proliferation. Cell Separation. Electrophoresis, Polyacrylamide Gel. Enzyme-Linked Immunosorbent Assay. Exocytosis. Flow Cytometry. Fluorescent Antibody Technique. Humans. Leukemia, Monocytic, Acute / metabolism. Microscopy, Electron, Transmission

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20921526.001).
  • [ISSN] 1550-6606
  • [Journal-full-title] Journal of immunology (Baltimore, Md. : 1950)
  • [ISO-abbreviation] J. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Transforming Growth Factor beta1
  •  go-up   go-down


50. Nakamura H, Dan S, Akashi T, Unno M, Yamori T: Absolute quantification of four isoforms of the class I phosphoinositide-3-kinase catalytic subunit by real-time RT-PCR. Biol Pharm Bull; 2007 Jun;30(6):1181-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Using this system, we investigated human monocytic leukemia cells (U937) to analyze expression of all four isoforms.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17541179.001).
  • [ISSN] 0918-6158
  • [Journal-full-title] Biological & pharmaceutical bulletin
  • [ISO-abbreviation] Biol. Pharm. Bull.
  • [Language] eng
  • [Publication-type] Comparative Study; Letter; Research Support, Non-U.S. Gov't
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Isoenzymes; EC 2.7.1.- / Phosphatidylinositol 3-Kinases
  •  go-up   go-down


51. Yoshikawa Y, Sasahara Y, Kitano Y, Kanazawa N, Shima H, Hashimoto-Tamaoki T: Upregulation of genes orchestrating keratinocyte differentiation, including the novel marker gene ID2, by contact sensitizers in human bulge-derived keratinocytes. J Biochem Mol Toxicol; 2010 Jan-Feb;24(1):10-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, we analyzed the molecular responses to certain contact sensitizers (2,4-dinitrochlorobenzene and NiSO(4)) and irritants (sodium dodecyl sulfate and benzalkonium chloride) in cultured human keratinocytes from the bulge region of a plucked hair follicle (bulge-derived keratinocytes [BDKs]) and compared these molecular responses to those with the human monocytic leukemia cell line, THP-1.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20146380.001).
  • [ISSN] 1099-0461
  • [Journal-full-title] Journal of biochemical and molecular toxicology
  • [ISO-abbreviation] J. Biochem. Mol. Toxicol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / ID2 protein, human; 0 / Inhibitor of Differentiation Protein 2; 0 / Interleukins; 0 / Irritants; 0 / NF-E2-Related Factor 2; 0 / NFE2L2 protein, human
  •  go-up   go-down


52. Ichiyama T, Hasegawa M, Hashimoto K, Matsushige T, Hirano R, Furukawa S: Cysteinyl leukotrienes induce macrophage inflammatory protein-1 in human monocytes/macrophages. Int Arch Allergy Immunol; 2009;148(2):147-53
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We examined MIP-1alpha and MIP-1beta production stimulated by CysLTs (LTC(4), LTD(4), and LTE(4)) in THP-1 cells, a human monocytic leukemia cell line, and peripheral blood mononuclear cells (PBMCs).


53. Gogălniceanu D, Trandafir V, Trandafir D, Popescu E: [Generalized gingival enlargement--early clinic manifestation in acute leukemia. Case report]. Rev Med Chir Soc Med Nat Iasi; 2010 Apr-Jun;114(2):576-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Generalized gingival enlargement--early clinic manifestation in acute leukemia. Case report].
  • [Transliterated title] Hiperplazia gingivală generalizată-- manifestare clinică precoce în leucemia acută. Prezentare de caz.
  • Leukemia is a hematological disorder arises from a hematopoietic stem cell characterized by a disordered differentiation and proliferation of neoplastic cells.
  • Rapidly forming generalized gingival hyperplasia is usually the first sign of this disease (especially in acute forms).
  • This case report describes a 54-year-old female who presented rapid gingival enlargement in only three weeks time, heralding the presence of acute monocytic leukemia (AML-FAB M5).
  • [MeSH-major] Gingival Hypertrophy / etiology. Leukemia, Monocytic, Acute / complications. Leukemia, Monocytic, Acute / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20701007.001).
  • [ISSN] 0048-7848
  • [Journal-full-title] Revista medico-chirurgicală̆ a Societă̆ţ̜ii de Medici ş̧i Naturaliş̧ti din Iaş̧i
  • [ISO-abbreviation] Rev Med Chir Soc Med Nat Iasi
  • [Language] rum
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Romania
  •  go-up   go-down


54. Li ZJ, Chen ZX, Cen JN, Lu J, He J: [Establishment of a nude mouse model of human monocytic leukemia with multi-organ infiltration]. Ai Zheng; 2006 Oct;25(10):1307-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Establishment of a nude mouse model of human monocytic leukemia with multi-organ infiltration].
  • BACKGROUND & OBJECTIVE: Acute leukemia is always accompanied by extramedullary infiltration, which may be the source of relapse.
  • METHODS: After being treated by splenectomy, cytoxan intraperitoneal injection, and sublethal irradiation, 4-and 6-week old BALB/c nu/nu mice were transplanted intravenously with 5x10(6) or 1x10(7) of SHI-1 human monocytic leukemic cells.
  • [MeSH-major] Disease Models, Animal. Leukemia, Monocytic, Acute / pathology. Leukemic Infiltration / pathology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17059783.001).
  • [Journal-full-title] Ai zheng = Aizheng = Chinese journal of cancer
  • [ISO-abbreviation] Ai Zheng
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] EC 3.1.3.48 / Antigens, CD45
  •  go-up   go-down


55. Perez-Campo FM, Borrow J, Kouskoff V, Lacaud G: The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors. Blood; 2009 May 14;113(20):4866-74
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors.
  • The monocytic leukemia zinc finger (MOZ) gene encodes a large multidomain protein that contains, besides other domains, 2 coactivation domains for the transcription factor Runx1/acute myeloid leukemia 1 and a histone acetyl transferase (HAT) catalytic domain.

  • MedlinePlus Health Information. consumer health - Stem Cells.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • SciCrunch. Marmoset Gene list: Data: Gene Annotation .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Genet. 1996 Sep;14(1):33-41 [8782817.001]
  • [Cites] Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3444-9 [8622955.001]
  • [Cites] Development. 1998 Feb;125(4):725-32 [9435292.001]
  • [Cites] Blood. 1998 May 1;91(9):3127-33 [9558366.001]
  • [Cites] Cancer Genet Cytogenet. 1999 Aug;113(1):70-2 [10459350.001]
  • [Cites] J Biol Chem. 1999 Oct 1;274(40):28528-36 [10497217.001]
  • [Cites] Nature. 2004 Dec 2;432(7017):625-30 [15577911.001]
  • [Cites] Trends Cardiovasc Med. 2004 Nov;14(8):314-7 [15596108.001]
  • [Cites] Cell. 2005 Sep 23;122(6):947-56 [16153702.001]
  • [Cites] Mol Cell. 2006 Jan 6;21(1):51-64 [16387653.001]
  • [Cites] Genes Dev. 2006 May 1;20(9):1175-86 [16651658.001]
  • [Cites] Genes Dev. 2006 May 15;20(10):1321-30 [16702405.001]
  • [Cites] J Immunol. 2006 Oct 15;177(8):5420-9 [17015728.001]
  • [Cites] J Neurosci. 2006 Nov 1;26(44):11359-70 [17079664.001]
  • [Cites] Science. 2007 Aug 3;317(5838):620-2 [17673651.001]
  • [Cites] Exp Cell Res. 2007 Oct 1;313(16):3604-15 [17765223.001]
  • [Cites] Oncogene. 2007 Oct 15;26(47):6697-714 [17934479.001]
  • [Cites] Cell. 2007 Nov 16;131(4):633-6 [18022353.001]
  • [Cites] Mol Cell Proteomics. 2008 Mar;7(3):459-72 [18045800.001]
  • [Cites] Leukemia. 2008 Mar;22(3):663-5 [17805331.001]
  • [Cites] Development. 2008 Apr;135(8):1525-35 [18339678.001]
  • [Cites] Biochem Biophys Res Commun. 1999 Dec 20;266(2):405-10 [10600516.001]
  • [Cites] Development. 2000 Jun;127(12):2537-48 [10821753.001]
  • [Cites] Nature. 2000 Nov 2;408(6808):92-6 [11081514.001]
  • [Cites] Leukemia. 2001 Jan;15(1):89-94 [11243405.001]
  • [Cites] EMBO Rep. 2001 Feb;2(2):113-8 [11258702.001]
  • [Cites] EMBO J. 2001 Apr 17;20(8):1952-62 [11296228.001]
  • [Cites] Oncogene. 2001 Jan 18;20(3):404-9 [11313971.001]
  • [Cites] Ann N Y Acad Sci. 2001 Jun;938:96-107; discussion 108 [11458531.001]
  • [Cites] EMBO J. 2001 Dec 17;20(24):7184-96 [11742995.001]
  • [Cites] Oncogene. 2002 Apr 18;21(17):2729-40 [11965546.001]
  • [Cites] Blood. 2002 Jul 15;100(2):458-66 [12091336.001]
  • [Cites] Cancer Cell. 2003 Mar;3(3):259-71 [12676584.001]
  • [Cites] Nucleic Acids Res. 2003 Jun 1;31(11):2735-44 [12771199.001]
  • [Cites] Development. 2003 Sep;130(17):4217-27 [12874139.001]
  • [Cites] Methods. 2003 Sep;31(1):24-32 [12893170.001]
  • [Cites] J Exp Med. 2004 Jan 5;199(1):5-14 [14707111.001]
  • [Cites] Blood. 2004 Feb 1;103(3):886-9 [14525762.001]
  • [Cites] Front Biosci. 2004 Jan 1;9:24-31 [14766340.001]
  • [Cites] Genet Res. 1981 Jun;37(3):303-9 [7262555.001]
  • [Cites] EMBO J. 1993 Jul;12(7):2715-21 [8334990.001]
  • [Cites] Cell. 1996 Jan 26;84(2):321-30 [8565077.001]
  • [Cites] Curr Opin Cell Biol. 1995 Dec;7(6):862-9 [8608017.001]
  • [Cites] Science. 1997 Nov 7;278(5340):1059-64 [9353180.001]
  • (PMID = 19264921.001).
  • [ISSN] 1528-0020
  • [Journal-full-title] Blood
  • [ISO-abbreviation] Blood
  • [Language] ENG
  • [Grant] United Kingdom / Cancer Research UK / / C147/A6058
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.3.1.48 / Histone Acetyltransferases; EC 2.3.1.48 / MOZ protein, mouse
  • [Other-IDs] NLM/ PMC2686138
  •  go-up   go-down


56. Ge Y, Rikihisa Y: Surface-exposed proteins of Ehrlichia chaffeensis. Infect Immun; 2007 Aug;75(8):3833-41
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Nineteen out of 22 OMP-1/P28 family proteins, including P28 (which previously was shown to be surface exposed), were detected in E. chaffeensis cultured in human monocytic leukemia THP-1 cells.

  • Hazardous Substances Data Bank. BIOTIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Infect Immun. 2001 Apr;69(4):2083-91 [11254561.001]
  • [Cites] Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W400-4 [15215419.001]
  • [Cites] Infect Immun. 2002 May;70(5):2700-3 [11953415.001]
  • [Cites] Infect Immun. 2002 Aug;70(8):4701-4 [12117987.001]
  • [Cites] J Mol Biol. 2004 Jul 16;340(4):783-95 [15223320.001]
  • [Cites] Infect Immun. 2004 Aug;72(8):4336-43 [15271888.001]
  • [Cites] Clin Diagn Lab Immunol. 1997 Nov;4(6):731-5 [9384299.001]
  • [Cites] Infect Immun. 1998 Jan;66(1):132-9 [9423849.001]
  • [Cites] J Bacteriol. 1998 Feb;180(3):505-13 [9457851.001]
  • [Cites] Infect Immun. 1998 Mar;66(3):1023-7 [9488391.001]
  • [Cites] Infect Immun. 1998 Mar;66(3):1252-7 [9488422.001]
  • [Cites] Biochem Biophys Res Commun. 1998 Jun 29;247(3):636-43 [9647746.001]
  • [Cites] Infect Immun. 1998 Nov;66(11):5406-13 [9784551.001]
  • [Cites] Infect Immun. 2004 Dec;72(12):7257-64 [15557651.001]
  • [Cites] Infect Immun. 2005 Jan;73(1):563-72 [15618196.001]
  • [Cites] J Immunol. 2005 Jun 1;174(11):6702-15 [15905510.001]
  • [Cites] J Bacteriol. 2005 Jul;187(14):4782-91 [15995193.001]
  • [Cites] Infect Immun. 2005 Aug;73(8):4853-63 [16040999.001]
  • [Cites] Proteomics. 2005 Jul;5(11):2718-28 [15986331.001]
  • [Cites] Am J Trop Med Hyg. 2005 Aug;73(2):400-9 [16103612.001]
  • [Cites] Infect Immun. 2005 Dec;73(12):8109-18 [16299305.001]
  • [Cites] Infect Immun. 2006 Jan;74(1):711-20 [16369028.001]
  • [Cites] Cell Microbiol. 2006 Mar;8(3):523-34 [16469062.001]
  • [Cites] Infect Immun. 2006 Mar;74(3):1873-82 [16495562.001]
  • [Cites] Proteomics. 2006 Mar;6(5):1530-49 [16470658.001]
  • [Cites] PLoS Genet. 2006 Feb;2(2):e21 [16482227.001]
  • [Cites] Cell Microbiol. 2006 Sep;8(9):1406-16 [16922860.001]
  • [Cites] Cell Microbiol. 2006 Sep;8(9):1475-87 [16922866.001]
  • [Cites] Microbes Infect. 2006 Aug;8(9-10):2452-8 [16880000.001]
  • [Cites] J Bacteriol. 2007 Mar;189(5):1998-2006 [17172334.001]
  • [Cites] Cell Microbiol. 2007 Mar;9(3):610-8 [16987329.001]
  • [Cites] Nat Protoc. 2006;1(1):192-9 [17406232.001]
  • [Cites] Microb Pathog. 2000 Feb;28(2):71-80 [10644493.001]
  • [Cites] Infect Immun. 2000 Mar;68(3):1125-33 [10678916.001]
  • [Cites] Infect Immun. 2000 Apr;68(4):2187-95 [10722619.001]
  • [Cites] Gene. 2000 May 2;248(1-2):59-68 [10806351.001]
  • [Cites] Microbiology. 2001 Jan;147(Pt 1):87-96 [11160803.001]
  • [Cites] J Immunol. 2001 Feb 1;166(3):1855-62 [11160232.001]
  • [Cites] Infect Immun. 1979 Nov;26(2):638-50 [121111.001]
  • [Cites] J Immunol. 1984 Aug;133(2):1010-5 [6736645.001]
  • [Cites] Science. 1986 Mar 14;231(4743):1299-302 [3945825.001]
  • [Cites] Infect Immun. 1989 Nov;57(11):3666-9 [2807542.001]
  • [Cites] Infect Immun. 1991 Sep;59(9):3199-204 [1715323.001]
  • [Cites] J Clin Microbiol. 1991 Dec;29(12):2741-5 [1757543.001]
  • [Cites] Am J Trop Med Hyg. 1994 Jan;50(1):52-8 [8304572.001]
  • [Cites] J Clin Microbiol. 1994 Sep;32(9):2107-12 [7814533.001]
  • [Cites] J Med Entomol. 1995 May;32(3):368-74 [7616529.001]
  • [Cites] Infect Immun. 1996 Jul;64(7):2643-8 [8698490.001]
  • [Cites] J Clin Microbiol. 1996 Nov;34(11):2853-5 [8897200.001]
  • [Cites] Infect Immun. 1997 Apr;65(4):1455-61 [9119487.001]
  • [Cites] J Clin Microbiol. 1997 Jul;35(7):1681-6 [9196173.001]
  • [Cites] J Clin Microbiol. 1997 Oct;35(10):2496-502 [9316896.001]
  • [Cites] J Immunol. 2002 Aug 1;169(3):1419-25 [12133967.001]
  • [Cites] Infect Immun. 2002 Sep;70(9):4772-6 [12183518.001]
  • [Cites] Science. 2003 Jan 10;299(5604):262-5 [12522254.001]
  • [Cites] Infect Immun. 2003 May;71(5):2516-24 [12704123.001]
  • [Cites] Cell Microbiol. 2003 Nov;5(11):809-20 [14531896.001]
  • [Cites] Infect Immun. 2002 Apr;70(4):1824-31 [11895944.001]
  • (PMID = 17517859.001).
  • [ISSN] 0019-9567
  • [Journal-full-title] Infection and immunity
  • [ISO-abbreviation] Infect. Immun.
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI030010; United States / NIAID NIH HHS / AI / R01 AI 30010
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bacterial Outer Membrane Proteins; 0 / Bacterial Proteins; 0 / Membrane Proteins; 0 / Succinimides; 0 / sulfo-N-hydroxysuccinimide-biotin; 6SO6U10H04 / Biotin
  • [Other-IDs] NLM/ PMC1951975
  •  go-up   go-down


57. Kim HK, Kim JE, Chung J, Lee DS, Han KS, Park S, Cho HI: Plasma level of stromal derived factor-1 (SDF-1) is increased in disseminated intravascular coagulation patients who have poor outcomes: in vitro effect of SDF-1 on coagulopathy. Thromb Res; 2007;120(4):559-66
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • SDF-1 did not affect the expression of surface TF protein and its function and the TF mRNA level in both monocytes and the monocytic leukemia cell line THP-1.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17239427.001).
  • [ISSN] 0049-3848
  • [Journal-full-title] Thrombosis research
  • [ISO-abbreviation] Thromb. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CXCL12 protein, human; 0 / Chemokine CXCL12; 0 / Chemokines, CXC; 0 / Thrombomodulin; 9035-58-9 / Thromboplastin
  •  go-up   go-down


58. He Q, Zhang J, Shi J, Zhu Z, Zhang L, Bu W, Guo L, Chen Y: The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials; 2010 Feb;31(6):1085-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Under the optimal conditions for the minimum HSA adsorbance, the phagocytosis of human THP-1 monocytic leukemia cell line-derived macrophages (THP-1 macrophages) and the hemolysis of human red blood cells (HRBCs) were investigated with MSNs and PEGylated MSNs.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2009 Elsevier Ltd. All rights reserved.
  • (PMID = 19880176.001).
  • [ISSN] 1878-5905
  • [Journal-full-title] Biomaterials
  • [ISO-abbreviation] Biomaterials
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biocompatible Materials; 0 / Blood Proteins; 30IQX730WE / Polyethylene Glycols; 7631-86-9 / Silicon Dioxide
  •  go-up   go-down


59. Espinoza JL, Takamatsu H, Lu X, Qi Z, Nakao S: Anti-moesin antibodies derived from patients with aplastic anemia stimulate monocytic cells to secrete TNF-alpha through an ERK1/2-dependent pathway. Int Immunol; 2009 Aug;21(8):913-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Anti-moesin antibodies derived from patients with aplastic anemia stimulate monocytic cells to secrete TNF-alpha through an ERK1/2-dependent pathway.
  • Antibodies specific to moesin, which are frequently detectable in the serum of patients with aplastic anemia (AA), can induce tumor necrosis factor-alpha (TNF-alpha) secretion from monocytes and a human monocytic leukemia cell line THP-1.
  • We investigated the mechanisms responsible for TNF-alpha secretion from monocytic cells induced by the auto-antibodies that are purified from the sera of AA patients.
  • Anti-moesin antibodies as well as their F(ab')(2) fragments induced the phosphorylation of ERK1/2 in monocytic cells and this effect was suppressed by the addition of an ERK1/2 inhibitor.


60. Wang Q, Li N, Wang X, Shen J, Hong X, Yu H, Zhang Y, Wan T, Zhang L, Wang J, Cao X: Membrane protein hMYADM preferentially expressed in myeloid cells is up-regulated during differentiation of stem cells and myeloid leukemia cells. Life Sci; 2007 Jan 9;80(5):420-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Membrane protein hMYADM preferentially expressed in myeloid cells is up-regulated during differentiation of stem cells and myeloid leukemia cells.
  • hMYADM is also closely related to many other eukaryotic proteins, which together form a novel and highly conserved MYADM-like family. hMYADM with 322-residue protein contains eight putative transmembrane segments and confocal microscopic analysis confirmed its membrane localization by using anti-hMYADM monoclonal antibody. hMYADM mRNA was selectively expressed in human monocytes, dendritic cells, promyeloid or monocytic leukemia cell lines, but not in CD4+, CD8+, CD19+ cells, nor in T cell leukemia or lymphocytic leukemia cell lines. hMYADM expression was also found in normal human bone marrow enriched for CD34+ stem cells, and the expression was up-regulated when these cells were induced to differentiate toward myeloid cells.
  • The mRNA expression level of hMYADM significantly increased in acute promyelocytic leukemia HL-60 and chronic myelogenous leukemia K562 cell line after phorbol myristate acetate (PMA)-induced differentiation.
  • Our study suggests that hMYADM is selectively expressed in myeloid cells, and involved in the myeloid differentiation process, indicating that hMYADM may be one useful membrane marker to monitor stem cell differentiation or myeloid leukemia differentiation.
  • [MeSH-major] Antigens, Differentiation / biosynthesis. Cell Differentiation. Cell Membrane / metabolism. Hematopoietic Stem Cells / metabolism. Leukemia, Myeloid / metabolism. Proteins / metabolism

  • Genetic Alliance. consumer health - Leukemia, Myeloid.
  • MedlinePlus Health Information. consumer health - Stem Cells.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17097684.001).
  • [ISSN] 0024-3205
  • [Journal-full-title] Life sciences
  • [ISO-abbreviation] Life Sci.
  • [Language] eng
  • [Databank-accession-numbers] GENBANK/ AY037147
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Antigens, Differentiation; 0 / MYADM protein, human; 0 / Myadm protein, mouse; 0 / Myelin and Lymphocyte-Associated Proteolipid Proteins; 0 / Proteins
  •  go-up   go-down


61. Kameoka M, Kitagawa Y, Utachee P, Jinnopat P, Dhepakson P, Isarangkura-na-ayuthaya P, Tokunaga K, Sato H, Komano J, Yamamoto N, Oguchi S, Natori Y, Ikuta K: Identification of the suppressive factors for human immunodeficiency virus type-1 replication using the siRNA mini-library directed against host cellular genes. Biochem Biophys Res Commun; 2007 Aug 3;359(3):729-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • J111 cells, a human acute monocytic leukemia cell line, were transfected with individual siRNA, followed by either infected or transfected with the HIV-1 molecular clone with luciferase reporter gene in 96-well plate format.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17560945.001).
  • [ISSN] 0006-291X
  • [Journal-full-title] Biochemical and biophysical research communications
  • [ISO-abbreviation] Biochem. Biophys. Res. Commun.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Small Interfering; 0 / Suppressor Factors, Immunologic
  •  go-up   go-down


62. Martínez-Poventud G, Fradera J, Pérez S, Fernández A, Pacheco E, Acabá L, López-Enriquez A, Román-Díaz A, Castro-Montalvo J, Vélez-García E: Aleukemic leukemia cutis preceding acute monocytic leukemia: a case report. P R Health Sci J; 2008 Sep;27(3):256-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aleukemic leukemia cutis preceding acute monocytic leukemia: a case report.
  • Aleukemic leukemia cutis is an extremely rare clinical presentation in patients who eventually develop acute leukemia, usually of monocytic lineage.
  • We report a case of a 33 years old female with leukemia cutis preceding the onset of acute monocytic leukemia by four months.
  • To our knowledge, this is the first documented case in Puerto Rico with the diagnosis of leukemia cutis preceding acute monocytic leukemia.
  • [MeSH-major] Leukemia, Monocytic, Acute / pathology. Leukemic Infiltration. Skin / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18782972.001).
  • [ISSN] 0738-0658
  • [Journal-full-title] Puerto Rico health sciences journal
  • [ISO-abbreviation] P R Health Sci J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Puerto Rico
  •  go-up   go-down


63. Aikawa Y, Katsumoto T, Zhang P, Shima H, Shino M, Terui K, Ito E, Ohno H, Stanley ER, Singh H, Tenen DG, Kitabayashi I: PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2. Nat Med; 2010 May;16(5):580-5, 1p following 585
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2.
  • Using an acute myeloid leukemia (AML) model induced by the leukemia-associated monocytic leukemia zinc finger (MOZ)-TIF2 fusion protein, we show here that AML can be cured by the ablation of leukemia stem cells.
  • Cells expressing high amounts of CSF1R (CSF1R(high) cells), but not those expressing low amounts of CSF1R (CSF1R(low) cells), showed potent leukemia-initiating activity.
  • Moreover, induction of AML was suppressed in CSF1R-deficient mice and CSF1R inhibitors slowed the progression of MOZ-TIF2-induced leukemia.
  • Thus, in this subtype of AML, leukemia stem cells are contained within the CSF1R(high) cell population, and we suggest that targeting of PU.1-mediated upregulation of CSF1R expression might be a useful therapeutic approach.

  • MedlinePlus Health Information. consumer health - Acute Myeloid Leukemia.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • SciCrunch. OMIM: Data: Gene Annotation .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Immunity. 2002 Nov;17(5):665-76 [12433372.001]
  • [Cites] Blood. 2007 Jul 1;110(1):323-33 [17360941.001]
  • [Cites] Cancer Cell. 2003 Mar;3(3):259-71 [12676584.001]
  • [Cites] J Leukoc Biol. 2004 Apr;75(4):612-23 [14726498.001]
  • [Cites] Cancer Res. 1987 Feb 1;47(3):874-80 [2433029.001]
  • [Cites] Nature. 1987 Sep 17-23;329(6136):259-61 [3476856.001]
  • [Cites] Cell. 1987 Nov 20;51(4):663-73 [2824063.001]
  • [Cites] J Clin Invest. 1988 Apr;81(4):1030-5 [2832442.001]
  • [Cites] J Cell Physiol. 1988 Apr;135(1):133-8 [3259234.001]
  • [Cites] Mol Cell Biol. 1994 Jan;14(1):373-81 [8264604.001]
  • [Cites] Mol Cell Biol. 1996 Mar;16(3):1231-40 [8622667.001]
  • [Cites] Nat Genet. 1996 Sep;14(1):33-41 [8782817.001]
  • [Cites] Nat Med. 1997 Jul;3(7):730-7 [9212098.001]
  • [Cites] EMBO J. 1998 Jul 1;17(13):3714-25 [9649441.001]
  • [Cites] Cancer Cell. 2004 Dec;6(6):587-96 [15607963.001]
  • [Cites] Blood. 2005 Apr 15;105(8):3127-32 [15637141.001]
  • [Cites] Blood. 2005 Sep 1;106(5):1590-600 [15914556.001]
  • [Cites] Cell Cycle. 2005 Jul;4(7):851-3 [15917650.001]
  • [Cites] Oncogene. 2006 Jan 5;25(1):147-51 [16170366.001]
  • [Cites] Genes Dev. 2006 May 1;20(9):1175-86 [16651658.001]
  • [Cites] Cancer Res. 2007 Nov 15;67(22):10677-85 [18006809.001]
  • [Cites] Cancer Sci. 2008 Aug;99(8):1523-7 [18754862.001]
  • [Cites] Haematologica. 2008 Oct;93(10):1591-3 [18698081.001]
  • [Cites] Blood. 2009 Jul 9;114(2):299-309 [19339695.001]
  • [Cites] Gene Ther. 2000 Jun;7(12):1063-6 [10871756.001]
  • [Cites] Nature. 2001 Nov 1;414(6859):105-11 [11689955.001]
  • [Cites] EMBO J. 2001 Dec 17;20(24):7184-96 [11742995.001]
  • [Cites] Blood. 2002 Jan 1;99(1):111-20 [11756160.001]
  • [Cites] Genes Dev. 2006 May 15;20(10):1321-30 [16702405.001]
  • [Cites] Mol Cancer Ther. 2006 Nov;5(11):2634-43 [17121910.001]
  • [Cites] Blood. 2007 May 1;109(9):3998-4005 [17227832.001]
  • [Cites] Nucleic Acids Res. 2003 Feb 15;31(4):e12 [12582257.001]
  • (PMID = 20418886.001).
  • [ISSN] 1546-170X
  • [Journal-full-title] Nature medicine
  • [ISO-abbreviation] Nat. Med.
  • [Language] ENG
  • [Grant] United States / NCI NIH HHS / CA / R01 CA041456-24; United States / NCI NIH HHS / CA / R01 CA032551; United States / NCI NIH HHS / CA / P01 CA066996; United States / NCI NIH HHS / CA / 5P30-CA13330; United States / NCI NIH HHS / CA / CA041456-24; United States / NCI NIH HHS / CA / R01-CA41456; United States / NCI NIH HHS / CA / CA32551; United States / NCI NIH HHS / CA / R01 CA041456; United States / NCI NIH HHS / CA / P30 CA013330; United States / NHLBI NIH HHS / HL / R01 HL112719
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Colony-Stimulating Factors; 0 / NCOA2 protein, human; 0 / Nuclear Receptor Coactivator 2; 0 / Proto-Oncogene Proteins; 0 / Receptors, Colony-Stimulating Factor; 0 / Recombinant Fusion Proteins; 0 / Trans-Activators; 0 / proto-oncogene protein Spi-1; 81627-83-0 / Macrophage Colony-Stimulating Factor; EC 2.7.10.1 / Receptor, Macrophage Colony-Stimulating Factor
  • [Other-IDs] NLM/ NIHMS265702; NLM/ PMC3039870
  •  go-up   go-down


64. Ferreri C, Kratzsch S, Brede O, Marciniak B, Chatgilialoglu C: Trans lipid formation induced by thiols in human monocytic leukemia cells. Free Radic Biol Med; 2005 May 1;38(9):1180-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Trans lipid formation induced by thiols in human monocytic leukemia cells.
  • Here we report the presence of trans lipids in human monocytic leukemia cell membranes (THP-1) before and after treatment with a 10 mM series of thiols.
  • [MeSH-major] Leukemia / metabolism. Membrane Lipids / biosynthesis. Phospholipids / biosynthesis. Sulfhydryl Compounds / physiology

  • MedlinePlus Health Information. consumer health - Leukemia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15808415.001).
  • [ISSN] 0891-5849
  • [Journal-full-title] Free radical biology & medicine
  • [ISO-abbreviation] Free Radic. Biol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Membrane Lipids; 0 / Phospholipids; 0 / Sulfhydryl Compounds
  •  go-up   go-down


65. Mun GI, Boo YC: Identification of CD44 as a senescence-induced cell adhesion gene responsible for the enhanced monocyte recruitment to senescent endothelial cells. Am J Physiol Heart Circ Physiol; 2010 Jun;298(6):H2102-11
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Senescent human umbilical vein endothelial cells (HUVECs) prepared by continuous subculturing in vitro showed higher binding affinity for monocytes (THP-1 cells, human acute monocytic leukemia cell line) compared with young cells.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20382854.001).
  • [ISSN] 1522-1539
  • [Journal-full-title] American journal of physiology. Heart and circulatory physiology
  • [ISO-abbreviation] Am. J. Physiol. Heart Circ. Physiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies; 0 / Antigens, CD44; 0 / CD44 protein, human; 0 / RNA, Small Interfering
  •  go-up   go-down


66. Kuo CC, Kuo CW, Liang CM, Liang SM: A transcriptomic and proteomic analysis of the effect of CpG-ODN on human THP-1 monocytic leukemia cells. Proteomics; 2005 Mar;5(4):894-906
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A transcriptomic and proteomic analysis of the effect of CpG-ODN on human THP-1 monocytic leukemia cells.
  • [MeSH-major] CpG Islands. Gene Expression Regulation, Neoplastic. Genetic Therapy / methods. Leukemia, Monocytic, Acute / therapy. Oligonucleotides / genetics. Proteomics / methods. Transcription, Genetic

  • MedlinePlus Health Information. consumer health - Genes and Gene Therapy.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15693060.001).
  • [ISSN] 1615-9853
  • [Journal-full-title] Proteomics
  • [ISO-abbreviation] Proteomics
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / DNA, Complementary; 0 / Oligonucleotides; 0 / RNA, Messenger; 20350-15-6 / Brefeldin A; EC 1.13.12.- / Luciferases; EC 3.4.21.4 / Trypsin
  •  go-up   go-down


67. Li L, Liu LB, Wang L, Zou P: [Effect of MLL-AF9 fusion gene silence of acute monocytic leukemia cell line THP-1 on cyclin-dependent kinase inhibitor p27 expression]. Zhonghua Xue Ye Xue Za Zhi; 2008 Jun;29(6):375-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Effect of MLL-AF9 fusion gene silence of acute monocytic leukemia cell line THP-1 on cyclin-dependent kinase inhibitor p27 expression].
  • [MeSH-major] Cyclin-Dependent Kinase Inhibitor p27 / metabolism. Leukemia, Monocytic, Acute / pathology. Myeloid-Lymphoid Leukemia Protein / genetics. Oncogene Proteins, Fusion / genetics. RNA Interference

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19031738.001).
  • [ISSN] 0253-2727
  • [Journal-full-title] Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • [ISO-abbreviation] Zhonghua Xue Ye Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / MLL-AF9 fusion protein, human; 0 / Oncogene Proteins, Fusion; 147604-94-2 / Cyclin-Dependent Kinase Inhibitor p27; 149025-06-9 / Myeloid-Lymphoid Leukemia Protein
  •  go-up   go-down


68. Amtmann E, Zöller M: Stimulation of CD95-induced apoptosis in T-cells by a subtype specific neutral sphingomyelinase inhibitor. Biochem Pharmacol; 2005 Apr 15;69(8):1141-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In contrast, T-cells (human T-cell lymphoma and PHA stimulated murine lymph node cells) and monocytic leukemia cells were lacking SMase activity at pH 8.0.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15794934.001).
  • [ISSN] 0006-2952
  • [Journal-full-title] Biochemical pharmacology
  • [ISO-abbreviation] Biochem. Pharmacol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD95; 0 / C11AG compound; 0 / Cell Extracts; 0 / Guanidines; 0 / Phytohemagglutinins; EC 3.1.4.12 / Sphingomyelin Phosphodiesterase
  •  go-up   go-down


69. Ji YY, Zhang WG, Chen YX, Zhao XM, He AL, Liu J, Wang JL, Wang FX, Zhang PY, Zhang WJ: [Efficiency of GHA priming therapy on patients with acute monocytic leukemia and its mechanism]. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb;18(1):213-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Efficiency of GHA priming therapy on patients with acute monocytic leukemia and its mechanism].
  • The aim of this study was to explore the clinical efficiency and side effects of GHA-priming therapy on patients with acute monocytic leukemia, and to analyze its mechanism.
  • 37 patients with refractory, relapse, hypocellular acute monocytic leukemia and elderly patients with AML-M(5) were treated with GHA-priming therapy (G-CSF, homoharringtonine and low dosage of cytarabine).
  • It is concluded that the GHA priming therapy can be used to treat patients with refractory, relapse, senile and hypocellular acute monocytic leukemia with satisfied response rate and low hematological and non-hematological toxicities.
  • MLAA-34 is a novel anti-apoptotic factor of acute monocytic leukemia.

  • Hazardous Substances Data Bank. CYTARABINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20137150.001).
  • [ISSN] 1009-2137
  • [Journal-full-title] Zhongguo shi yan xue ye xue za zhi
  • [ISO-abbreviation] Zhongguo Shi Yan Xue Ye Xue Za Zhi
  • [Language] CHI
  • [Publication-type] Clinical Trial; English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Harringtonines; 04079A1RDZ / Cytarabine; 143011-72-7 / Granulocyte Colony-Stimulating Factor; 6FG8041S5B / homoharringtonine
  •  go-up   go-down


70. Chen W, Rassidakis GZ, Medeiros LJ: Nucleophosmin gene mutations in acute myeloid leukemia. Arch Pathol Lab Med; 2006 Nov;130(11):1687-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nucleophosmin gene mutations in acute myeloid leukemia.
  • CONTEXT: Heterozygous mutation of the nucleophosmin gene (NPM1) has recently been described as one of the most frequent genetic lesions in acute myeloid leukemia (AML). OBJECTIVE:.
  • NPM1-mutated AML is preferentially associated with AML with monocytic differentiation (in particular FAB M5b), lack of CD34, normal cytogenetics, FLT3 gene mutations, and a trend toward favorable clinical outcome, especially in patients without FLT3 gene mutation.
  • [MeSH-major] Leukemia, Myeloid, Acute / genetics. Mutation. Nuclear Proteins / genetics


71. Liu Y, Sun ZG, Ren WC, Tian M, Li Y, Li CY: [Influences of Mycobacterium tuberculosis on the levels of human acute monocytic leukemia cell line THP-1 apoptosis and death]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Aug;31(4):417-22
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Influences of Mycobacterium tuberculosis on the levels of human acute monocytic leukemia cell line THP-1 apoptosis and death].
  • OBJECTIVE: To explore the influences of Mycobacterium tuberculosis on the levels of human acute monocytic leukemia cell line THP-1 apoptosis and death.
  • METHODS: Human acute monocytic leukemia cell line THP-1 were infected with Mycobacterium tuberculosis strains H37Ra, H37Rv, or Beijing genotype (BJTB), respectively, to construct the infection models.
  • [MeSH-major] Leukemia, Monocytic, Acute. Mycobacterium tuberculosis / pathogenicity

  • Genetic Alliance. consumer health - Tuberculosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19771726.001).
  • [ISSN] 1000-503X
  • [Journal-full-title] Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae
  • [ISO-abbreviation] Zhongguo Yi Xue Ke Xue Yuan Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


72. Tariku Y, Hymete A, Hailu A, Rohloff J: Essential-oil composition, antileishmanial, and toxicity study of Artemisia abyssinica and Satureja punctata ssp. punctata from Ethiopia. Chem Biodivers; 2010 Apr;7(4):1009-18
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Essential oils of Artemisia abyssinica and Satureja punctata ssp. punctata from Ethiopia were analyzed by GC and GC/MS, and screened for leishmanicidal activity against promastigote and axenic amastigotes of Leishmania donovani and L. aethiopica, including toxicity studies on human monocytic leukemia cells (THP-1) and erythrocytes in vitro.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20397218.001).
  • [ISSN] 1612-1880
  • [Journal-full-title] Chemistry & biodiversity
  • [ISO-abbreviation] Chem. Biodivers.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Antiprotozoal Agents; 0 / Oils, Volatile
  •  go-up   go-down


73. Shadat NM, Koide N, Khuda II, Dagvadorj J, Tumurkhuu G, Naiki Y, Komatsu T, Yoshida T, Yokochi T: Retinoblastoma protein-interacting zinc finger 1 (RIZ1) regulates the proliferation of monocytic leukemia cells via activation of p53. Cancer Invest; 2010 Oct;28(8):806-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Retinoblastoma protein-interacting zinc finger 1 (RIZ1) regulates the proliferation of monocytic leukemia cells via activation of p53.
  • The role of retinoblastoma protein-interacting zinc finger 1 (RIZ1) on the cell growth of mouse and human monocytic leukemia cells was examined.
  • Therefore, it is suggested that RIZ1 negatively regulated the cell proliferation of monocytic leukemia cells via activation of p53.
  • [MeSH-major] DNA-Binding Proteins / pharmacology. Histone-Lysine N-Methyltransferase / pharmacology. Leukemia, Myeloid / pathology. Nuclear Proteins / pharmacology. Transcription Factors / pharmacology. Tumor Suppressor Protein p53 / metabolism

  • Genetic Alliance. consumer health - Retinoblastoma.
  • National BioResource Project. culture/stock collections - NBRP resources .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20594067.001).
  • [ISSN] 1532-4192
  • [Journal-full-title] Cancer investigation
  • [ISO-abbreviation] Cancer Invest.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA Primers; 0 / DNA-Binding Proteins; 0 / Nuclear Proteins; 0 / Transcription Factors; 0 / Tumor Necrosis Factor-alpha; 0 / Tumor Suppressor Protein p53; EC 2.1.1.43 / Histone-Lysine N-Methyltransferase; EC 2.1.1.43 / PRDM2 protein, human
  •  go-up   go-down


74. Li ZJ, Chen ZX, Lu J, Cen JN, He J, Guo LC: [Growth and infiltration of human monocytic leukemia cell in nude mice: a model for central nervous system leukemia]. Zhonghua Xue Ye Xue Za Zhi; 2006 Jun;27(6):374-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Growth and infiltration of human monocytic leukemia cell in nude mice: a model for central nervous system leukemia].
  • OBJECTIVE: To establish a model of human monocytic leukemia with CNS infiltration in BALB/c nude mice.
  • METHODS: BALB/c nu/nu mice pre-treated by splenectomy, cytoxan intraperitoneal injection, and sublethal irradiation (SCI), were transplanted intravenously with 1 x 10(7) of human monocytic leukemic SHI-1 cells.
  • In brain leukemia cells were filled in the subdural space and pia-arachnoid, covered the surface of cerebrum, cerebellum, spread along the virchow-robin space on the surface of pia mater, and eventually invaded the brain parenchyma.
  • CONCLUSION: SHI-1 cells could engrafted in the SCI-nu/nu mice, form an efficient and reproducible experimental model of CNSL and systematic leukemia.
  • [MeSH-major] Central Nervous System Neoplasms. Leukemia, Experimental. Leukemia, Monocytic, Acute

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17147225.001).
  • [ISSN] 0253-2727
  • [Journal-full-title] Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
  • [ISO-abbreviation] Zhonghua Xue Ye Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  •  go-up   go-down


75. McGrattan P, Logan A, Humphreys M, Bowers M: Jumping translocation in acute monocytic leukemia (M5b) with alternative breakpoint sites in the long arm of donor chromosome 3. Med Oncol; 2010 Sep;27(3):667-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Jumping translocation in acute monocytic leukemia (M5b) with alternative breakpoint sites in the long arm of donor chromosome 3.
  • An 86-year-old man presented with acute hepatic failure, worsening thrombocytopenia, and anemia having been diagnosed and managed expectantly with cytogenetically normal RAEB-1.
  • After 20 months a diagnosis of disease transformation to acute monocytic leukemia (M5b) was made.
  • Conventional G-banded analysis of unstimulated peripheral blood cultures detected the proximal 3q1?2 JT clone involving recipient chromosome 10 several weeks after transformation to acute monocytic leukemia.
  • There have been fewer than 70 cases of acquired JTs reported in the literature, including one myeloproliferative neoplasm and five acute myeloid leukemias involving a single breakpoint site on donor chromosome 3.
  • [MeSH-major] Chromosome Breakpoints. Chromosomes, Human, Pair 3 / genetics. Leukemia, Monocytic, Acute / genetics. Translocation, Genetic

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Leukemia. 2000 Jan;14(1):119-22 [10637486.001]
  • [Cites] Leukemia. 2000 Sep;14(9):1630-3 [10995010.001]
  • [Cites] Haematologica. 2006 Dec;91(12):1596-604 [17145595.001]
  • [Cites] Pathol Biol (Paris). 2007 Feb;55(1):37-48 [16697122.001]
  • [Cites] Blood. 2007 Jan 15;109(2):431-48 [16960150.001]
  • [Cites] Leukemia. 1998 Sep;12(9):1411-6 [9737690.001]
  • [Cites] Cancer Genet Cytogenet. 2000 Apr 1;118(1):35-41 [10731588.001]
  • [Cites] Leukemia. 1995 Apr;9(4):634-9 [7723397.001]
  • [Cites] Leuk Res. 2004 Oct;28(10):1075-9 [15289020.001]
  • [Cites] Oncogene. 2007 Sep 6;26(41):5991-6001 [17369841.001]
  • [Cites] Cancer Genet Cytogenet. 1999 Mar;109(2):144-9 [10087950.001]
  • [Cites] Br J Haematol. 2006 Jan;132(2):162-7 [16398650.001]
  • [Cites] Cancer Genet Cytogenet. 1999 Jan 15;108(2):149-53 [9973944.001]
  • [Cites] Genes Chromosomes Cancer. 2007 Aug;46(8):717-23 [17444494.001]
  • [Cites] Cancer Genet Cytogenet. 1988 Jul 1;33(1):29-33 [3164238.001]
  • [Cites] Cancer Genet Cytogenet. 1991 Feb;51(2):189-94 [1993304.001]
  • [Cites] Blood. 1997 Mar 15;89(6):2079-88 [9058730.001]
  • [Cites] Cytogenet Cell Genet. 1988;48(4):224-7 [3248378.001]
  • [Cites] Genes Chromosomes Cancer. 1999 Apr;24(4):295-8 [10092126.001]
  • [Cites] Cancer Genet Cytogenet. 1993 Nov;71(1):22-6 [8275449.001]
  • [Cites] Cancer Genet Cytogenet. 1999 Feb;109(1):40-4 [9973958.001]
  • [Cites] Blood. 1998 Mar 1;91(5):1514-9 [9473214.001]
  • [Cites] Cancer Genet Cytogenet. 1997 Oct 1;98(1):20-7 [9309114.001]
  • [Cites] Blood. 1998 Mar 1;91(5):1732-41 [9473240.001]
  • (PMID = 19629764.001).
  • [ISSN] 1559-131X
  • [Journal-full-title] Medical oncology (Northwood, London, England)
  • [ISO-abbreviation] Med. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


76. Kawakami C, Inoue A, Takitani K, Yuki M, Tamai H: Successful treatment of acute monocytic leukemia with intracranial hemorrhage as the first manifestation. Pediatr Int; 2010 Aug;52(4):e218-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successful treatment of acute monocytic leukemia with intracranial hemorrhage as the first manifestation.
  • [MeSH-major] Intracranial Hemorrhages / complications. Leukemia, Monocytic, Acute / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20958870.001).
  • [ISSN] 1442-200X
  • [Journal-full-title] Pediatrics international : official journal of the Japan Pediatric Society
  • [ISO-abbreviation] Pediatr Int
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Australia
  •  go-up   go-down


77. Shirkoohi R: [Ability of actin-regulatory protein, gelsolin in induction of monocytic leukemia cell differentiation]. Hokkaido Igaku Zasshi; 2006 Mar;81(2):159-67
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Ability of actin-regulatory protein, gelsolin in induction of monocytic leukemia cell differentiation].
  • [MeSH-major] Actins / physiology. Gelsolin / physiology. Leukemia, Monocytic, Acute / pathology

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16669119.001).
  • [ISSN] 0367-6102
  • [Journal-full-title] [Hokkaido igaku zasshi] The Hokkaido journal of medical science
  • [ISO-abbreviation] Hokkaido Igaku Zasshi
  • [Language] jpn
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Actins; 0 / Cyclin-Dependent Kinase Inhibitor Proteins; 0 / Gelsolin
  •  go-up   go-down


78. Yu H, Li Y, Gao C, Fabien L, Jia Y, Lu J, Silberstein LE, Pinkus GS, Ye K, Chai L, Luo HR: Relevant mouse model for human monocytic leukemia through Cre/lox-controlled myeloid-specific deletion of PTEN. Leukemia; 2010 May;24(5):1077-80
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Relevant mouse model for human monocytic leukemia through Cre/lox-controlled myeloid-specific deletion of PTEN.
  • [MeSH-major] Disease Models, Animal. Integrases / metabolism. Leukemia, Monocytic, Acute / pathology. Myeloid Cells / pathology. PTEN Phosphohydrolase / physiology

  • Genetic Alliance. consumer health - Leukemia, Myeloid.
  • COS Scholar Universe. author profiles.
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Immunity. 2003 Nov;19(5):689-99 [14614856.001]
  • [Cites] Leukemia. 2006 Jun;20(6):911-28 [16642045.001]
  • [Cites] Nature. 2006 May 25;441(7092):475-82 [16598206.001]
  • [Cites] Nature. 2006 May 25;441(7092):518-22 [16633340.001]
  • [Cites] Blood. 2006 Oct 1;108(7):2349-57 [16763213.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14836-41 [16988010.001]
  • [Cites] Blood. 2007 May 1;109(9):4028-37 [17202315.001]
  • [Cites] Blood. 2009 May 14;113(20):4930-41 [19286998.001]
  • (PMID = 20220776.001).
  • [ISSN] 1476-5551
  • [Journal-full-title] Leukemia
  • [ISO-abbreviation] Leukemia
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / P01 DK080665; United States / NHLBI NIH HHS / HL / R01 HL092437
  • [Publication-type] Letter
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Reactive Oxygen Species; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt; EC 2.7.7.- / Cre recombinase; EC 2.7.7.- / Integrases; EC 3.1.3.48 / Pten protein, mouse; EC 3.1.3.67 / PTEN Phosphohydrolase
  • [Other-IDs] NLM/ NIHMS586913; NLM/ PMC4134872
  •  go-up   go-down


79. Tariku Y, Hymete A, Hailu A, Rohloff J: Constituents, antileishmanial activity and toxicity profile of volatile oil from berries of Croton macrostachyus. Nat Prod Commun; 2010 Jun;5(6):975-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The oil was tested for its in vitro antileishmanial activity on two Leishmania strains, and its toxicity on the human monocytic leukemia (THP-1) cell line and erythrocytes from sheep blood.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20614838.001).
  • [ISSN] 1934-578X
  • [Journal-full-title] Natural product communications
  • [ISO-abbreviation] Nat Prod Commun
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antiprotozoal Agents; 0 / Oils, Volatile; 0 / Plant Oils
  •  go-up   go-down


80. Lu J, Sheng GY, Zou X, Xu XJ, Zhao XM, Bai ST, Xu PR: [Effects of FMS-like tyrosine kinase 3 targeted RNA interference on proliferation and apoptosis of acute monocytic leukemia cell line THP-1]. Zhonghua Er Ke Za Zhi; 2007 Aug;45(8):615-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Effects of FMS-like tyrosine kinase 3 targeted RNA interference on proliferation and apoptosis of acute monocytic leukemia cell line THP-1].
  • OBJECTIVE: FMS-like tyrosine kinase 3 (FLT3) is a receptor tyrosine kinase that is constitutively activated in (70-90)% pediatric patients with acute myeloid leukemia (AML) and appears to confer an adverse prognosis.
  • The aim of the present study was to investigate the efficacy of suppression of FLT3 induced by small hairpin interfering RNA (shRNA) on myeloproliferation and apoptosis in an acute monocytic leukemia (AMOL) cell line THP-1.
  • [MeSH-major] Apoptosis / drug effects. Cell Proliferation / drug effects. Leukemia, Monocytic, Acute / pathology. RNA, Small Interfering / pharmacology. fms-Like Tyrosine Kinase 3 / metabolism

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18021537.001).
  • [ISSN] 0578-1310
  • [Journal-full-title] Zhonghua er ke za zhi = Chinese journal of pediatrics
  • [ISO-abbreviation] Zhonghua Er Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / RNA, Small Interfering; EC 2.7.1.- / TYRO3 protein, human; EC 2.7.10.1 / Protein-Tyrosine Kinases; EC 2.7.10.1 / Receptor Protein-Tyrosine Kinases; EC 2.7.10.1 / fms-Like Tyrosine Kinase 3
  •  go-up   go-down


81. Wang WH, Palumbo AM, Tan YJ, Reid GE, Tepe JJ, Bruening ML: Identification of p65-associated phosphoproteins by mass spectrometry after on-plate phosphopeptide enrichment using polymer-oxotitanium films. J Proteome Res; 2010 Jun 4;9(6):3005-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • When combined with MALDI-MS/MS, the enrichment technique reveals nine phosphopeptides from p65-associated proteins immunoprecipitated from human acute monocytic leukemia (THP-1) cell nuclear extracts.
  • [MeSH-minor] Amino Acid Sequence. Cell Extracts / chemistry. Cell Line, Tumor. Cell Nucleus / chemistry. Computational Biology. Humans. Immunoprecipitation. Leukemia, Monocytic, Acute. Molecular Sequence Data. Peptide Fragments / chemistry. Peptide Fragments / metabolism. Polymers / chemistry. Titanium / chemistry. Trypsin / chemistry. Trypsin / metabolism. Tumor Necrosis Factor-alpha / chemistry. Tumor Necrosis Factor-alpha / metabolism

  • COS Scholar Universe. author profiles.
  • PhosphoSitePlus. gene/protein/disease-specific - PhosphoSitePlus® - comprehensive post-translational modification resource .
  • Hazardous Substances Data Bank. TITANIUM .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20380454.001).
  • [ISSN] 1535-3907
  • [Journal-full-title] Journal of proteome research
  • [ISO-abbreviation] J. Proteome Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cell Extracts; 0 / Peptide Fragments; 0 / Phosphopeptides; 0 / Phosphoproteins; 0 / Polymers; 0 / Transcription Factor RelA; 0 / Tumor Necrosis Factor-alpha; D1JT611TNE / Titanium; EC 3.4.21.4 / Trypsin
  •  go-up   go-down


82. Kuniyasu H, Yano S, Sasaki T, Sasahira T, Sone S, Ohmori H: Colon cancer cell-derived high mobility group 1/amphoterin induces growth inhibition and apoptosis in macrophages. Am J Pathol; 2005 Mar;166(3):751-60
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To investigate HMGB1/amphoterin effects on macrophages, U937 human monocytic leukemia cells and rat peritoneal and human alveolar macrophages were examined.
  • U937 cells expressed low levels of an HMGB1/amphoterin receptor, receptor for advanced glycation end-products (RAGE), whereas RAGE production was induced in differentiated phorbol 12-myristate 13-acetate (PMA)-U937 cells.

  • Hazardous Substances Data Bank. 12-O-TETRADECANOYLPHORBOL-13-ACETATE .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Cell Sci. 2000 Feb;113 ( Pt 4):611-20 [10652254.001]
  • [Cites] Biochem Biophys Res Commun. 1999 Aug 27;262(2):350-4 [10462478.001]
  • [Cites] J Biol Chem. 2000 Sep 1;275(35):26792-8 [10854431.001]
  • [Cites] FASEB J. 2000 Sep;14(12):1705-14 [10973919.001]
  • [Cites] Matrix Biol. 2000 Sep;19(5):377-87 [10980414.001]
  • [Cites] Mol Biol Cell. 2000 Dec;11(12):4347-58 [11102528.001]
  • [Cites] J Biol Chem. 2000 Dec 22;275(51):40096-105 [11007787.001]
  • [Cites] Cancer Lett. 2001 Apr 10;165(1):1-10 [11248412.001]
  • [Cites] J Cell Biol. 2001 Mar 19;152(6):1197-206 [11257120.001]
  • [Cites] Shock. 2001 Apr;15(4):247-53 [11303722.001]
  • [Cites] J Biol Chem. 2001 Jul 27;276(30):28113-20 [11369774.001]
  • [Cites] Mol Med. 2001 May;7(5):293-300 [11474575.001]
  • [Cites] Mol Cell Biol. 2001 Oct;21(19):6706-17 [11533257.001]
  • [Cites] Prostate. 2001 Sep 15;49(1):19-29 [11550207.001]
  • [Cites] Oncogene. 2001 Sep 27;20(43):6263-8 [11593437.001]
  • [Cites] J Endotoxin Res. 2001;7(4):315-21 [11717586.001]
  • [Cites] J Pathol. 2002 Feb;196(2):163-70 [11793367.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2002 Oct;283(4):L849-58 [12225962.001]
  • [Cites] Cancer Res. 2002 Dec 1;62(23):7042-9 [12460925.001]
  • [Cites] Oncol Rep. 2003 Mar-Apr;10(2):445-8 [12579287.001]
  • [Cites] J Immunol. 2003 Mar 1;170(5):2409-16 [12594264.001]
  • [Cites] Nat Cell Biol. 2003 Sep;5(9):781-92 [12907943.001]
  • [Cites] Oncol Rep. 2003 Nov-Dec;10(6):1863-8 [14534709.001]
  • [Cites] Pathobiology. 2004;71(3):129-36 [15051925.001]
  • [Cites] Nature. 1979 May 24;279(5711):328-31 [450085.001]
  • [Cites] J Immunol Methods. 1984 May 25;70(2):257-68 [6609997.001]
  • [Cites] Annu Rev Med. 1987;38:417-32 [3555304.001]
  • [Cites] Biochem Biophys Res Commun. 1993 Mar 15;191(2):503-8 [7681667.001]
  • [Cites] J Biol Chem. 1995 Mar 31;270(13):7394-8 [7706284.001]
  • [Cites] Nature. 1996 Mar 7;380(6569):75-9 [8598911.001]
  • [Cites] J Natl Cancer Inst. 1996 Aug 21;88(16):1146-51 [8757194.001]
  • [Cites] J Immunol. 1996 Sep 15;157(6):2660-5 [8805671.001]
  • [Cites] Cell Growth Differ. 1997 Jan;8(1):47-52 [8993833.001]
  • [Cites] J Immunol. 1998 Sep 1;161(5):2490-500 [9725248.001]
  • [Cites] Oncogene. 1998 Oct 8;17(14):1855-69 [9778052.001]
  • [Cites] Nature. 2000 May 18;405(6784):354-60 [10830965.001]
  • (PMID = 15743787.001).
  • [ISSN] 0002-9440
  • [Journal-full-title] The American journal of pathology
  • [ISO-abbreviation] Am. J. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Culture Media, Conditioned; 0 / Glycosylation End Products, Advanced; 0 / HMGB1 Protein; 0 / Nitrites; 0 / Oligonucleotides; 0 / Oligonucleotides, Antisense; 0 / Recombinant Proteins; EC 1.14.13.39 / NOS2 protein, human; EC 1.14.13.39 / Nitric Oxide Synthase; EC 1.14.13.39 / Nitric Oxide Synthase Type II; EC 1.14.13.39 / Nos2 protein, rat; NI40JAQ945 / Tetradecanoylphorbol Acetate
  • [Other-IDs] NLM/ PMC1602344
  •  go-up   go-down


83. Xu N, Liu XL, DU QF, Liu Z, Zhong M, Lin R, Song LL, Yi ZS, Meng FY, Zhou SY: [CD56 and CD11b antigen expressions in patients with acute monocytic leukemia and the clinical implications]. Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug;29(8):1605-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [CD56 and CD11b antigen expressions in patients with acute monocytic leukemia and the clinical implications].
  • OBJECTIVE: To investigate the expressions of cell surface differentiation antigen CD56 and CD11b antigen in acute monocytic leukemic (AML-M(5)) cells and their clinical significance.
  • Compared with the patients positive for both CD56 and CD11b, those negative for both CD56 and CD11b showed increased peripheral blood white blood cell (WBC) count and also increased blast and progenitor cells in the bone marrow (P<0.05); the former patients often had karyotypic abnormalities, commonly involving 11q23 aberrations (P<0.05), whereas the latter patients presented more likely with extramedullary infiltration and refractory leukemia (P<0.01) with lowered complete remission rate and shortened median survival time (P<0.01).
  • CD56-positive patients were more likely to have karyotypic abnormalities and refractory leukemia than CD11b-postive patients (P<0.05), but the peripheral blood WBC counts, bone marrow blast and progenitor cells, extramedullary infiltration, complete remission rate or median survival time showed no significant differences between them (P>0.05).
  • These patients frequently develop extramedullary infiltration and refractory leukemia often with poor prognosis.
  • [MeSH-major] Antigens, CD11b / metabolism. Antigens, CD56 / metabolism. Gene Expression Regulation. Leukemia, Monocytic, Acute / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19726305.001).
  • [ISSN] 1673-4254
  • [Journal-full-title] Nan fang yi ke da xue xue bao = Journal of Southern Medical University
  • [ISO-abbreviation] Nan Fang Yi Ke Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD11b; 0 / Antigens, CD56
  •  go-up   go-down


84. Tanaka T, Fukunaga Y, Itoh H, Doi K, Yamashita J, Chun TH, Inoue M, Masatsugu K, Saito T, Sawada N, Sakaguchi S, Arai H, Nakao K: Therapeutic potential of thiazolidinediones in activation of peroxisome proliferator-activated receptor gamma for monocyte recruitment and endothelial regeneration. Eur J Pharmacol; 2005 Jan 31;508(1-3):255-65
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Troglitazone and pioglitazone, the two thiazolidinediones, as well as 15-deoxy-delta12,14-prostaglandin J2 inhibited in a dose-dependent manner the serum-induced proliferation of THP-1 (human monocytic leukemia cells) and of U937 (human monoblastic leukemia cells), which permanently express PPARgamma.
  • Oral administration of troglitazone to Watanabe heritable hyperlipidemic (WHHL) rabbits after balloon injury suppressed acute recruitment of monocytes/macrophages and accelerated re-endothelialization.

  • Hazardous Substances Data Bank. PIOGLITAZONE .
  • Hazardous Substances Data Bank. ALL-TRANS-RETINOIC ACID .
  • Hazardous Substances Data Bank. ALITRETINOIN .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15680279.001).
  • [ISSN] 0014-2999
  • [Journal-full-title] European journal of pharmacology
  • [ISO-abbreviation] Eur. J. Pharmacol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / 15-deoxy-delta(12,14)-prostaglandin J2; 0 / CCR2 protein, human; 0 / Chemokine CCL2; 0 / Chromans; 0 / PPAR gamma; 0 / RNA, Messenger; 0 / Receptors, CCR2; 0 / Receptors, Chemokine; 0 / Thiazolidinediones; 0 / Vascular Endothelial Growth Factor A; 5300-03-8 / alitretinoin; 5688UTC01R / Tretinoin; I66ZZ0ZN0E / troglitazone; RXY07S6CZ2 / Prostaglandin D2; X4OV71U42S / pioglitazone
  •  go-up   go-down


85. Adati N, Huang MC, Suzuki T, Suzuki H, Kojima T: High-resolution analysis of aberrant regions in autosomal chromosomes in human leukemia THP-1 cell line. BMC Res Notes; 2009;2:153
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] High-resolution analysis of aberrant regions in autosomal chromosomes in human leukemia THP-1 cell line.
  • BACKGROUND: THP-1 is a human monocytic leukemia cell line derived from a patient with acute monocytic leukemia.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Genet. 2009 May;41(5):553-62 [19377474.001]
  • [Cites] Leuk Res. 2000 Jan;24(1):39-46 [10634644.001]
  • [Cites] Nature. 2006 May 25;441(7092):475-82 [16598206.001]
  • [Cites] Leukemia. 2006 May;20(5):757-66 [16541141.001]
  • [Cites] J Comput Biol. 2006 Mar;13(2):215-28 [16597236.001]
  • [Cites] Cancer Res. 1999 Sep 1;59(17):4233-6 [10485463.001]
  • [Cites] Tohoku J Exp Med. 1998 Oct;186(2):99-119 [10223614.001]
  • [Cites] Hum Mol Genet. 1999 Feb;8(2):185-93 [9931326.001]
  • [Cites] Leukemia. 1994 Sep;8(9):1579-84 [8090034.001]
  • [Cites] Blood. 1994 Oct 15;84(8):2431-5 [7919362.001]
  • [Cites] Experientia. 1991 Jan 15;47(1):22-31 [1999239.001]
  • [Cites] Semin Hematol. 1986 Jul;23(3):223-36 [3092357.001]
  • [Cites] Int J Cancer. 1980 Aug;26(2):171-6 [6970727.001]
  • [Cites] Cancer Res. 1982 Apr;42(4):1530-6 [6949641.001]
  • [Cites] Genes Chromosomes Cancer. 2003 Apr;36(4):393-401 [12619163.001]
  • [Cites] Biochem Biophys Res Commun. 2000 Oct 14;277(1):62-5 [11027640.001]
  • [Cites] Genes Chromosomes Cancer. 2000 Dec;29(4):333-8 [11066077.001]
  • [Cites] Oncogene. 2008 Sep 18;27(41):5443-53 [18794879.001]
  • (PMID = 19635138.001).
  • [ISSN] 1756-0500
  • [Journal-full-title] BMC research notes
  • [ISO-abbreviation] BMC Res Notes
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2729307
  •  go-up   go-down


86. Sato Y, Yokoyama A, Shibata K, Akimoto Y, Ogino S, Nodasaka Y, Kohgo T, Tamura K, Akasaka T, Uo M, Motomiya K, Jeyadevan B, Ishiguro M, Hatakeyama R, Watari F, Tohji K: Influence of length on cytotoxicity of multi-walled carbon nanotubes against human acute monocytic leukemia cell line THP-1 in vitro and subcutaneous tissue of rats in vivo. Mol Biosyst; 2005 Jul;1(2):176-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Influence of length on cytotoxicity of multi-walled carbon nanotubes against human acute monocytic leukemia cell line THP-1 in vitro and subcutaneous tissue of rats in vivo.
  • In this paper, we investigated the activation of the human acute monocytic leukemia cell line THP-1 in vitro and the response in subcutaneous tissue in vivo to CNTs of different lengths.
  • [MeSH-minor] Animals. Cell Line, Tumor. Culture Media / chemistry. Culture Media / pharmacology. Humans. Inflammation / etiology. Leukemia, Monocytic, Acute / metabolism. Leukemia, Monocytic, Acute / pathology. Male. Microscopy, Electron, Scanning. Microscopy, Electron, Transmission. Nanostructures / chemistry. Nanostructures / ultrastructure. Nanotechnology / methods. Rats. Rats, Wistar. Spectrophotometry, Infrared. Subcutaneous Tissue / pathology. Subcutaneous Tissue / ultrastructure. Tumor Necrosis Factor-alpha / metabolism

  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16880981.001).
  • [ISSN] 1742-206X
  • [Journal-full-title] Molecular bioSystems
  • [ISO-abbreviation] Mol Biosyst
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Culture Media; 0 / Nanotubes, Carbon; 0 / Tumor Necrosis Factor-alpha
  •  go-up   go-down


87. Lee SH, Park C, Jin CY, Kim GY, Moon SK, Hyun JW, Lee WH, Choi BT, Kwon TK, Yoo YH, Choi YH: Involvement of extracellular signal-related kinase signaling in esculetin induced G1 arrest of human leukemia U937 cells. Biomed Pharmacother; 2008 Dec;62(10):723-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Involvement of extracellular signal-related kinase signaling in esculetin induced G1 arrest of human leukemia U937 cells.
  • This study was conducted to further elucidate the possible mechanisms by which esculetin, a coumarin compound, exerts its anti-proliferative action on cultured human monocytic leukemia U937 cells.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18222060.001).
  • [ISSN] 1950-6007
  • [Journal-full-title] Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie
  • [ISO-abbreviation] Biomed. Pharmacother.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Cyclin E; 0 / E2F1 Transcription Factor; 0 / Retinoblastoma Protein; 0 / Umbelliferones; 147604-94-2 / Cyclin-Dependent Kinase Inhibitor p27; EC 2.7.11.22 / Cyclin-Dependent Kinase 2; EC 2.7.11.22 / Cyclin-Dependent Kinase 4; EC 2.7.11.24 / Extracellular Signal-Regulated MAP Kinases; SM2XD6V944 / esculetin
  •  go-up   go-down


88. Li ZJ, Chen ZX, Cen JN, He J: [Overexpression of tissue inhibitor of metalloprotease-2 promotes proliferation and infiltration of human monocytic leukemia cells]. Zhonghua Yi Xue Za Zhi; 2006 Sep 12;86(34):2409-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Overexpression of tissue inhibitor of metalloprotease-2 promotes proliferation and infiltration of human monocytic leukemia cells].
  • OBJECTIVE: To investigate the functional role of human tissue inhibitor of metalloprotease (TIMP)-2 gene on the proliferation and infiltrating capability of human monocytic leukemic cells.
  • METHODS: Human monocytic leukemic cells of the line SHI-1 were cultured and the TIMP-2 expression on the cell membrane was detected by flow cytometry (FCM).
  • Human bone marrow matrix cells (BMMC) of leukemia patient and SHI-1/TIMP-2 cells or SHI-1/MSCV cells were put into the upper layers as experimental groups, and SHI-1/TIMP-2 cells or SHI-1/MSCV cells only, without human BMMC, were put into the upper layers as control groups.
  • Thirty days later 8 mice from each group were killed to observe the tumorigenesis in the organs, especially the central nervous system leukemia (CNL).
  • [MeSH-major] Cell Membrane / metabolism. Cell Proliferation. Leukemia, Monocytic, Acute / metabolism. Leukemia, Monocytic, Acute / pathology. Tissue Inhibitor of Metalloproteinase-2 / biosynthesis
  • [MeSH-minor] Animals. Cell Line, Tumor. Cell Survival. Flow Cytometry. Humans. Leukemia, Experimental / genetics. Leukemia, Experimental / metabolism. Leukemia, Experimental / pathology. Male. Mice. Mice, Inbred BALB C. Mice, Nude. Neoplasm Invasiveness. Neoplasm Transplantation / methods. Transfection. Transplantation, Heterologous

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17156653.001).
  • [ISSN] 0376-2491
  • [Journal-full-title] Zhonghua yi xue za zhi
  • [ISO-abbreviation] Zhonghua Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 127497-59-0 / Tissue Inhibitor of Metalloproteinase-2
  •  go-up   go-down


89. Haga A, Komazaki S, Funasaka T, Hashimoto K, Yokoyama Y, Watanabe H, Raz A, Nagase H: AMF/G6PI induces differentiation of leukemic cells via an unknown receptor that differs from gp78. Leuk Lymphoma; 2006 Oct;47(10):2234-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The human acute monocytic leukemia line does not express gp78 and its motile activity is not enhanced by AMF though it is well differentiated by AMF exposure.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • antibodies-online. View related products from antibodies-online.com (subscription/membership/fee required).
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17071500.001).
  • [ISSN] 1042-8194
  • [Journal-full-title] Leukemia & lymphoma
  • [ISO-abbreviation] Leuk. Lymphoma
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Receptors, Cytokine; 9007-49-2 / DNA; EC 5.3.1.9 / Glucose-6-Phosphate Isomerase; EC 6.3.2.- / Amfr protein, mouse; EC 6.3.2.19 / AMFR protein, human; EC 6.3.2.19 / Receptors, Autocrine Motility Factor; EC 6.3.2.19 / Ubiquitin-Protein Ligases
  •  go-up   go-down


90. Chen YX, Wang WP, Zhang PY, Zhang WG, Liu J, Ma XR: [Expression of genes psma6 and slc25a4 in patients with acute monocytic leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct;17(5):1168-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expression of genes psma6 and slc25a4 in patients with acute monocytic leukemia].
  • The aim of this study was to investigate the expression levels of genes psma6 and slc25a4 in bone marrow of patients with acute monocytic leukemia and their correlation with clinical features and prognosis.
  • The expression levels of genes psma6 and slc25a4 in AML-M5 leukemia cells, normal blood cells and non-leukemia cells were detected by real-time quantitative RT-PCR and compared each other.
  • The results showed that the expression levels of psma6 mRNA in AML-M5 leukemia cells was lower than that in non AML-M5 leukemia cells, non-leukemia cells and normal blood cells.
  • The expression level of psma6 in AML-M5 patients with complete remission was higher than that in AML-M5 patients without remission.
  • The expression level of P27K protein in AML-M5 and AL correlated to leukocyte count in peripheral blood and LDH content.
  • The overexpression of slc25a4 mRNA was found in AML-M5, but there was no significant difference in slc25a4 mRNA expression between the patients with complete remission and those without remission.
  • It is concluded that the expression level of psma6 is probably a new prognostic indicator of acute monocytic leukemia, slc25a4 may be a novel gene of antigen associated with acute monocytic leukemia.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19840444.001).
  • [ISSN] 1009-2137
  • [Journal-full-title] Zhongguo shi yan xue ye xue za zhi
  • [ISO-abbreviation] Zhongguo Shi Yan Xue Ye Xue Za Zhi
  • [Language] CHI
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Adenine Nucleotide Translocator 1; EC 3.4.25.1 / PSMA6 protein, human; EC 3.4.25.1 / Proteasome Endopeptidase Complex
  •  go-up   go-down


91. Traore K, Trush MA, George M Jr, Spannhake EW, Anderson W, Asseffa A: Signal transduction of phorbol 12-myristate 13-acetate (PMA)-induced growth inhibition of human monocytic leukemia THP-1 cells is reactive oxygen dependent. Leuk Res; 2005 Aug;29(8):863-79
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Signal transduction of phorbol 12-myristate 13-acetate (PMA)-induced growth inhibition of human monocytic leukemia THP-1 cells is reactive oxygen dependent.
  • Human monocytic THP-1 cells can be induced to differentiate to macrophages when treated with phorbol 12-myristate 13-acetate (PMA).

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. 12-O-TETRADECANOYLPHORBOL-13-ACETATE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15978937.001).
  • [ISSN] 0145-2126
  • [Journal-full-title] Leukemia research
  • [ISO-abbreviation] Leuk. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] England
  • [Chemical-registry-number] 0 / 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one; 0 / Antioxidants; 0 / CDKN1A protein, human; 0 / Cell Cycle Proteins; 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / Flavonoids; 0 / RNA, Messenger; 0 / Reactive Oxygen Species; 0 / Retinoblastoma Protein; 56937-68-9 / phorbolol myristate acetate; EC 2.7.11.13 / Protein Kinase C; EC 2.7.11.22 / CDC2-CDC28 Kinases; EC 2.7.11.22 / CDK2 protein, human; EC 2.7.11.22 / Cyclin-Dependent Kinase 2; EC 2.7.11.24 / Extracellular Signal-Regulated MAP Kinases; NI40JAQ945 / Tetradecanoylphorbol Acetate
  •  go-up   go-down


92. Himeji M, Ohtsuki T, Fukazawa H, Tanaka M, Yazaki S, Ui S, Nishio K, Yamamoto H, Tasaka K, Mimura A: Difference of growth-inhibitory effect of Scutellaria baicalensis-producing flavonoid wogonin among human cancer cells and normal diploid cell. Cancer Lett; 2007 Jan 8;245(1-2):269-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Methanol extract from cultured Scutellaria baicalensis cells inhibited the proliferation of human monocytic leukemia cell line THP-1 and human osteogenic sarcoma cell line HOS.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16497434.001).
  • [ISSN] 0304-3835
  • [Journal-full-title] Cancer letters
  • [ISO-abbreviation] Cancer Lett.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Drugs, Chinese Herbal; 0 / Flavanones; 0 / Flavonoids; 0 / Growth Inhibitors; 0 / Plant Extracts; 347Q89U4M5 / baicalin; 49QAH60606 / baicalein; 632-85-9 / wogonin
  •  go-up   go-down


93. Kajiwara R, Goto H, Yanagimachi M, Kuroki F, Fujii H, Takahashi H, Yokota S: [Recurrent spontaneous regression of aleukemic leukemia cutis in a girl with acute monocytic leukemia]. Rinsho Ketsueki; 2006 Aug;47(8):764-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Recurrent spontaneous regression of aleukemic leukemia cutis in a girl with acute monocytic leukemia].
  • Aleukemic leukemia cutis is a rare form of leukemia manifestation, defined as a skin infiltration of leukemic cells with no evidence of leukemia in the bone marrow.
  • Bone marrow aspiration revealed the predominance of monocytic blasts (76.4%), and the patient was diagnosed as having acute monocytic leukemia (M5b) with leukemia cutis.
  • [MeSH-major] Leukemia / diagnosis. Leukemia / etiology. Leukemia, Monocytic, Acute / complications. Neoplasm Regression, Spontaneous

  • MedlinePlus Health Information. consumer health - Leukemia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16986716.001).
  • [ISSN] 0485-1439
  • [Journal-full-title] [Rinshō ketsueki] The Japanese journal of clinical hematology
  • [ISO-abbreviation] Rinsho Ketsueki
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


94. Sohn H, Kim KW, Kang HB, Won CJ, Kim WS, Lee B, Kwon OJ, Koh WJ, Shin SJ, Kim HJ: Induction of macrophage death by clinical strains of Mycobacterium kansasii. Microb Pathog; 2010 May;48(5):160-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In addition, SM-1 and 2693-20 also induced massive cell death in BMDM and THP-1 acute monocytic leukemia cells, while the slow growing strains induced significantly lower levels of cell death.

  • Genetic Alliance. consumer health - Mycobacterium Kansasii.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Elsevier Ltd. All rights reserved.
  • (PMID = 20211241.001).
  • [ISSN] 1096-1208
  • [Journal-full-title] Microbial pathogenesis
  • [ISO-abbreviation] Microb. Pathog.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cytokines; 0 / Tumor Necrosis Factor-alpha; EC 3.4.22.- / Caspases
  •  go-up   go-down


95. Aires V, Hichami A, Filomenko R, Plé A, Rébé C, Bettaieb A, Khan NA: Docosahexaenoic acid induces increases in [Ca2+]i via inositol 1,4,5-triphosphate production and activates protein kinase C gamma and -delta via phosphatidylserine binding site: implication in apoptosis in U937 cells. Mol Pharmacol; 2007 Dec;72(6):1545-56
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We investigated, in monocytic leukemia U937 cells, the effects of docosahexaenoic acid (DHA; 22:6 n-3) on calcium signaling and determined the implication of phospholipase C (PLC) and protein kinase C (PKC) in this pathway.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17878267.001).
  • [ISSN] 1521-0111
  • [Journal-full-title] Molecular pharmacology
  • [ISO-abbreviation] Mol. Pharmacol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Phosphatidylserines; 25167-62-8 / Docosahexaenoic Acids; 85166-31-0 / Inositol 1,4,5-Trisphosphate; EC 2.7.1.- / protein kinase C gamma; EC 2.7.11.13 / Protein Kinase C; EC 2.7.11.13 / Protein Kinase C-delta
  •  go-up   go-down


96. Lee KS, Dubey VS, Kolattukudy PE, Song CH, Shin AR, Jung SB, Yang CS, Kim SY, Jo EK, Park JK, Kim HJ: Diacyltrehalose of Mycobacterium tuberculosis inhibits lipopolysaccharide- and mycobacteria-induced proinflammatory cytokine production in human monocytic cells. FEMS Microbiol Lett; 2007 Feb;267(1):121-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diacyltrehalose of Mycobacterium tuberculosis inhibits lipopolysaccharide- and mycobacteria-induced proinflammatory cytokine production in human monocytic cells.
  • These lipids were purified using thin-layer chromatography, and their ability to induce proinflammatory cytokines in human monocytes and in a human acute monocytic leukemia cell line (THP-1) was examined.
  • None of the lipids tested induced significant interleukin (IL)-12p40 or tumor necrosis factor (TNF)-alpha production in monocytic cells.

  • Genetic Alliance. consumer health - Tuberculosis.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17156119.001).
  • [ISSN] 0378-1097
  • [Journal-full-title] FEMS microbiology letters
  • [ISO-abbreviation] FEMS Microbiol. Lett.
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / AI35272; United States / NIAID NIH HHS / AI / AI46582
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cytokines; 0 / Interleukin-12 Subunit p40; 0 / Interleukin-6; 0 / Lipids; 0 / Tumor Necrosis Factor-alpha; B8WCK70T7I / Trehalose
  •  go-up   go-down


97. Lee SH, Kim EJ, Suk K, Kim IS, Lee WH: TL1A induces the expression of TGF-β-inducible gene h3 (βig-h3) through PKC, PI3K, and ERK in THP-1 cells. Cell Immunol; 2010;266(1):61-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In order to find out whether the TL1A-induced inflammatory activation of macrophages is associated with the up-regulation of βig-h3 expression, the human acute monocytic leukemia cell line (THP-1) was stimulated with either recombinant human TL1A- or DR3-specific monoclonal antibodies.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • (PMID = 20863486.001).
  • [ISSN] 1090-2163
  • [Journal-full-title] Cellular immunology
  • [ISO-abbreviation] Cell. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Monoclonal; 0 / Enzyme Inhibitors; 0 / Extracellular Matrix Proteins; 0 / NF-kappa B; 0 / Protein Kinase Inhibitors; 0 / Receptors, Tumor Necrosis Factor, Member 25; 0 / Recombinant Proteins; 0 / TNFRSF25 protein, human; 0 / TNFSF15 protein, human; 0 / Transforming Growth Factor beta; 0 / Tumor Necrosis Factor Ligand Superfamily Member 15; 148710-76-3 / betaIG-H3 protein; EC 2.7.1.- / Phosphatidylinositol 3-Kinases; EC 2.7.11.13 / Protein Kinase C; EC 2.7.11.24 / Extracellular Signal-Regulated MAP Kinases
  •  go-up   go-down


98. Healy NC, O'Connor R: Sequestration of PDLIM2 in the cytoplasm of monocytic/macrophage cells is associated with adhesion and increased nuclear activity of NF-kappaB. J Leukoc Biol; 2009 Mar;85(3):481-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sequestration of PDLIM2 in the cytoplasm of monocytic/macrophage cells is associated with adhesion and increased nuclear activity of NF-kappaB.
  • To investigate this, we used the human monocytic leukemia cell line THP-1 that can differentiate into adherent macrophages and the adherent murine macrophage cell line RAW264.7.
  • In differentiated cells, PDLIM2 exhibited retarded mobility indicative of serine phosphorylation, which could be reversed by phosphatases and by inhibition of protein kinase C or ERK kinases.
  • In nondifferentiated THP-1 cells, PDLIM2 was located predominantly in the nucleus, whereas in differentiated cells, PDLIM2 was located predominantly in the cytoplasm.

  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19052146.001).
  • [ISSN] 1938-3673
  • [Journal-full-title] Journal of leukocyte biology
  • [ISO-abbreviation] J. Leukoc. Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Adaptor Proteins, Signal Transducing; 0 / LIM Domain Proteins; 0 / Microfilament Proteins; 0 / NF-kappa B; 0 / PDLIM2 protein, human; 0 / Pdlim2 protein, mouse; 0 / Tumor Necrosis Factor-alpha; EC 6.3.2.19 / Ubiquitin-Protein Ligases
  •  go-up   go-down


99. Zhou B, Ju SG, Ju SW, Xie F, Zhang XG: [Establishment of human acute monocytic leukemia model in severe combined immunodeficient (SCID) mice and the analysis of pathological changes]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jun;23(6):501-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Establishment of human acute monocytic leukemia model in severe combined immunodeficient (SCID) mice and the analysis of pathological changes].
  • AIM: To establish a model of human M5 leukemia and investigate the pathomorphological change in severe combined immunodeficient (SCID) mice after being transplanted with SHI-1 cells.
  • CONCLUSION: The SHI-1/SCID mice was constructed, which provided a useful tool to investigate acute monocytic leukemia(AML).
  • [MeSH-major] Leukemia, Monocytic, Acute / metabolism. Leukemia, Monocytic, Acute / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17553342.001).
  • [ISSN] 1007-8738
  • [Journal-full-title] Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology
  • [ISO-abbreviation] Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / 4-1BB Ligand; 0 / Antigens, CD14
  •  go-up   go-down


100. Hattori T, Amano H, Nagai Y, Ishikawa O: Leukemia cutis in a patient with acute monocytic leukemia presenting as unique facial erythema. J Dermatol; 2008 Oct;35(10):671-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Leukemia cutis in a patient with acute monocytic leukemia presenting as unique facial erythema.
  • She had been diagnosed as having acute monocytic leukemia (French-American-British classification, M5b) based on the histological findings of bone marrow.
  • Specific cutaneous lesions could occur in acute monocytic leukemia more frequently than in other types of leukemia, but rarely show symmetrical edematous erythema limited to the face.
  • [MeSH-major] Erythema / diagnosis. Facial Dermatoses / diagnosis. Leukemia, Monocytic, Acute / pathology. Leukemic Infiltration / diagnosis. Skin / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19017048.001).
  • [ISSN] 0385-2407
  • [Journal-full-title] The Journal of dermatology
  • [ISO-abbreviation] J. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down






Advertisement